JPH01242540A - Novel chalcone derivative and antiulcer agent containing said derivative as active ingredient - Google Patents
Novel chalcone derivative and antiulcer agent containing said derivative as active ingredientInfo
- Publication number
- JPH01242540A JPH01242540A JP6576888A JP6576888A JPH01242540A JP H01242540 A JPH01242540 A JP H01242540A JP 6576888 A JP6576888 A JP 6576888A JP 6576888 A JP6576888 A JP 6576888A JP H01242540 A JPH01242540 A JP H01242540A
- Authority
- JP
- Japan
- Prior art keywords
- added
- compound
- water
- formula
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- GVSPXQVUXHMUMA-MDWZMJQESA-N (e)-3-(3,5-ditert-butyl-4-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one Chemical compound C1=CC(OC)=CC=C1C(=O)\C=C\C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 GVSPXQVUXHMUMA-MDWZMJQESA-N 0.000 title claims description 5
- 239000003699 antiulcer agent Substances 0.000 title abstract description 9
- 239000004480 active ingredient Substances 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 139
- 239000000126 substance Substances 0.000 claims abstract description 15
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 5
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 5
- 125000005530 alkylenedioxy group Chemical group 0.000 claims abstract description 4
- -1 3-isopentyl Chemical group 0.000 claims description 51
- 229910052739 hydrogen Inorganic materials 0.000 claims description 22
- 239000001257 hydrogen Substances 0.000 claims description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 4
- 238000006243 chemical reaction Methods 0.000 abstract description 57
- 238000002360 preparation method Methods 0.000 abstract description 14
- 239000002994 raw material Substances 0.000 abstract description 4
- 125000000217 alkyl group Chemical group 0.000 abstract description 3
- 229910052736 halogen Inorganic materials 0.000 abstract description 2
- 150000002367 halogens Chemical class 0.000 abstract description 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 111
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 89
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 81
- 239000000243 solution Substances 0.000 description 72
- 239000011541 reaction mixture Substances 0.000 description 53
- 239000000203 mixture Substances 0.000 description 52
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 48
- 238000000862 absorption spectrum Methods 0.000 description 44
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 43
- 239000007787 solid Substances 0.000 description 39
- 238000002844 melting Methods 0.000 description 38
- 230000008018 melting Effects 0.000 description 38
- 239000002904 solvent Substances 0.000 description 34
- 238000001819 mass spectrum Methods 0.000 description 32
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 25
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 23
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 23
- 238000001816 cooling Methods 0.000 description 23
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 22
- 238000001914 filtration Methods 0.000 description 18
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 18
- 239000000843 powder Substances 0.000 description 18
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 16
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 16
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 14
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 239000012141 concentrate Substances 0.000 description 12
- 235000008504 concentrate Nutrition 0.000 description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 239000003208 petroleum Substances 0.000 description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 9
- 230000000767 anti-ulcer Effects 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 239000012312 sodium hydride Substances 0.000 description 9
- 229910000104 sodium hydride Inorganic materials 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 230000002378 acidificating effect Effects 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000003480 eluent Substances 0.000 description 8
- 239000012280 lithium aluminium hydride Substances 0.000 description 8
- 239000001294 propane Substances 0.000 description 8
- 125000006239 protecting group Chemical group 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 7
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 7
- 229910000027 potassium carbonate Inorganic materials 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 6
- 229920002261 Corn starch Polymers 0.000 description 6
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 6
- 150000001788 chalcone derivatives Chemical class 0.000 description 6
- 235000005513 chalcones Nutrition 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 239000008120 corn starch Substances 0.000 description 6
- 229940099112 cornstarch Drugs 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical group C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 6
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- 229940061627 chloromethyl methyl ether Drugs 0.000 description 5
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000012299 nitrogen atmosphere Substances 0.000 description 5
- YLLIGHVCTUPGEH-UHFFFAOYSA-M potassium;ethanol;hydroxide Chemical class [OH-].[K+].CCO YLLIGHVCTUPGEH-UHFFFAOYSA-M 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- CSCPPACGZOOCGX-MICDWDOJSA-N 1-deuteriopropan-2-one Chemical compound [2H]CC(C)=O CSCPPACGZOOCGX-MICDWDOJSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 101150041968 CDC13 gene Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 238000010531 catalytic reduction reaction Methods 0.000 description 3
- ONPSRCNNSZSSMH-UHFFFAOYSA-N chloroform;hexane;methanol Chemical compound OC.ClC(Cl)Cl.CCCCCC ONPSRCNNSZSSMH-UHFFFAOYSA-N 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- LBOVMDOAMWYGHK-UHFFFAOYSA-N ethanol;methylsulfinylmethane Chemical compound CCO.CS(C)=O LBOVMDOAMWYGHK-UHFFFAOYSA-N 0.000 description 3
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- VLXSIHLNPYRFFN-UHFFFAOYSA-N 1,4-dioxane;methanol Chemical compound OC.C1COCCO1 VLXSIHLNPYRFFN-UHFFFAOYSA-N 0.000 description 2
- QRBAILXEWUGUQB-UHFFFAOYSA-N 1-[2-hydroxy-4,6-bis(methoxymethoxy)phenyl]ethanone Chemical compound COCOC1=CC(O)=C(C(C)=O)C(OCOC)=C1 QRBAILXEWUGUQB-UHFFFAOYSA-N 0.000 description 2
- SULYEHHGGXARJS-UHFFFAOYSA-N 2',4'-dihydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1O SULYEHHGGXARJS-UHFFFAOYSA-N 0.000 description 2
- BVFFOAHQDACPFD-UHFFFAOYSA-N 4-(methoxymethoxy)benzaldehyde Chemical compound COCOC1=CC=C(C=O)C=C1 BVFFOAHQDACPFD-UHFFFAOYSA-N 0.000 description 2
- JRHHJNMASOIRDS-UHFFFAOYSA-N 4-ethoxybenzaldehyde Chemical compound CCOC1=CC=C(C=O)C=C1 JRHHJNMASOIRDS-UHFFFAOYSA-N 0.000 description 2
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 description 2
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000001341 hydroxy propyl starch Substances 0.000 description 2
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- VRDSPVUFCCVMCF-UHFFFAOYSA-N 1-[2,4,6-tris(methoxymethoxy)phenyl]ethanone Chemical compound COCOC1=CC(OCOC)=C(C(C)=O)C(OCOC)=C1 VRDSPVUFCCVMCF-UHFFFAOYSA-N 0.000 description 1
- KVFDJBFPVMQYFO-UHFFFAOYSA-N 1-[2-hydroxy-4-(methoxymethoxy)phenyl]ethanone Chemical compound COCOC1=CC=C(C(C)=O)C(O)=C1 KVFDJBFPVMQYFO-UHFFFAOYSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 235000018782 Dacrydium cupressinum Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 235000013697 Pinus resinosa Nutrition 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000008062 acetophenones Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- HUMNYLRZRPPJDN-KWCOIAHCSA-N benzaldehyde Chemical group O=[11CH]C1=CC=CC=C1 HUMNYLRZRPPJDN-KWCOIAHCSA-N 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940077716 histamine h2 receptor antagonists for peptic ulcer and gord Drugs 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000006201 parenteral dosage form Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野]
本発明は、芳香族化合物、特にカルコン誘導体及び該誘
導体を有効成分とする抗潰瘍剤に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to aromatic compounds, particularly chalcone derivatives, and antiulcer agents containing the derivatives as active ingredients.
本発明に係るカルコン誘導体は、文献未載の新規物質で
あって、医薬として有用であり、例えば抗潰瘍剤の技術
分野において重用される。The chalcone derivative according to the present invention is a novel substance that has not been described in any literature and is useful as a medicine, for example, it is heavily used in the technical field of anti-ulcer agents.
〔従来の技術および問題点]
近年、ストレス、薬剤による刺激、胃酸の過剰分泌等の
原因による消化性潰瘍の患者が増加しており、その治療
のために、制酸剤、抗コリン剤、ヒスタミンH2受容体
拮抗剤等の開発が進められている。しかし、これらの薬
剤は潰瘍の根治という点から見れば理想的な優れた薬剤
までには至っていない。[Prior art and problems] In recent years, the number of patients with peptic ulcers due to stress, irritation from drugs, excessive secretion of gastric acid, etc. has been increasing. Development of H2 receptor antagonists and the like is progressing. However, these drugs have not reached the level of ideal and excellent drugs from the point of view of completely curing ulcers.
そこで、より優れた抗潰瘍作用を有する物質が要求され
ていた。Therefore, there has been a need for substances with better anti-ulcer effects.
本発明者等は、上述した問題点を解決すべく鋭意研究を
行った結果、本発明のカルコン誘導体に抗潰瘍作用のあ
ることを見出すに至った。すなわち本発明は、一般式
[式中、
R1〜6は、同−又は異なり、水素、OH,X 、ある
いはOX基を表わすか(但しXは、OH、ハロゲン若し
くはアルコキシル基で置換されてもよい直鎖アルキル基
を表わす)、又は、隣接する基と一緒になってアルキレ
ンジオキシを表わしく但し、すべてが水素原子を表わす
ことはない);
Aは、OH又は0−Y−Zを表わしく但しYは、直鎖ア
ルキレンを表わし;Zは、カルボキシル、アルコキシカ
ルボニル又は水酸基を表わす);を表わし;
・−一一一は、単結合又は不飽和結合を意味する。The present inventors conducted intensive research to solve the above-mentioned problems, and as a result, they discovered that the chalcone derivative of the present invention has an antiulcer effect. That is, the present invention relates to the general formula [wherein R1 to R6 are the same or different and represent hydrogen, OH, A represents OH or 0-Y-Z; However, Y represents a straight chain alkylene; Z represents a carboxyl, alkoxycarbonyl or hydroxyl group; -111 means a single bond or an unsaturated bond.
但し、BがゝC< 2′位のAがOHを表わし且つ次の
(イ)又は(ロ)の場合の化合物を除く:(イ) 5′
位がプロピルまたは3−イソペンチル基で置換された化
合物、
(ロ) 4′位(及び/又は6′位)、3位及び4位が
Oll iで置換された化合物。〕で示されるカルコン
誘導体及びそれを有効成分として含有する抗潰瘍剤であ
る。However, this excludes compounds in which B is ゝC<2', A represents OH, and the following (a) or (b) is satisfied: (a) 5'
Compounds substituted with a propyl or 3-isopentyl group at position; (b) Compounds substituted with Olli at the 4'-position (and/or 6'-position), 3-position and 4-position. ] and an antiulcer agent containing it as an active ingredient.
一般式(1)の化合物において、Xの内、直鎖アルキル
基としては、メチル、エチル基等が含まれ、ハロゲンと
しては、塩基、臭素、ヨウ素又は弗素が含まれる。アル
キレンジオキシ基としては、メチレンジオキシ、エチレ
ンジオキシ基等が含まれる。In the compound of general formula (1), straight-chain alkyl groups in X include methyl, ethyl groups, etc., and halogens include bases, bromine, iodine, or fluorine. Examples of the alkylenedioxy group include methylenedioxy and ethylenedioxy groups.
また、Yの内、直鎖アルキレンとしては、メチレン、エ
チレン、等が含まれる。Zの内、アルコキシカルボニル
基としては、例えばカルボキシル基の11を上記した各
種アルキル基に置換したものが広く包含される。Further, among Y, linear alkylene includes methylene, ethylene, and the like. Among Z, the alkoxycarbonyl group broadly includes, for example, those in which 11 of the carboxyl group is substituted with the various alkyl groups described above.
不飽和結合としては、二重結合を意味する。The unsaturated bond means a double bond.
本発明においては、上記した遊離のカルコン誘導体のほ
か、保護基で保護された化合物も包含されるし、それら
の塩類、エステル類等も本発明に包含されることは当然
のことである。In addition to the above-mentioned free chalcone derivatives, the present invention includes compounds protected with protective groups, and it is a matter of course that the present invention also includes their salts, esters, and the like.
本発明に係る化合物(1)は、例えば下記式(II)で
示されるヒドロキシ置換アセトフェノン類と(III)
で示されるヒドロキシ置換ベンズアルデヒド類を原料と
して、次のような方法で製造することができる。Compound (1) according to the present invention includes, for example, a hydroxy-substituted acetophenone represented by the following formula (II) and (III)
It can be produced by the following method using the hydroxy-substituted benzaldehyde represented by as a raw material.
1’lH
例えば、これらの原料化合物のOH基を一部又は全部保
護して、 (II’)、(II″)、(Ill’)の化
合物とし、両者を反応せしめてカルコン骨格を有する化
合物(IV)又は(■′)を製造する:反応式(A)(
II ’) (II″)(III ’)次
いでこれらのカルコン誘導体(IV)又は(■′)を還
元して、双方のフェニル基を結合している炭化水素鎖の
二重結合を単結合(V)又は(V′)にした後、保護基
を除去して目的化合物(Vl)を得る:反応式(B)
(V[)
上記反応において、原料化合物(IIL (I[[)に
保護基を導入する反応は、例えば、ジイソプロピルエチ
ルアミンの存在下、クロロメチルメチルエーテルと原料
化合物とを室温又は加温しながら反応せしめればよいが
、必要に応じてジメチルアミノピリジン等の塩基の存在
下反応を行なってもよく、また、他の保護基導入反応も
適宜使用できる。1'lH For example, by protecting some or all of the OH groups of these starting compounds to form compounds (II'), (II''), and (Ill'), and reacting both to form compounds having a chalcone skeleton ( IV) or (■'): Reaction formula (A) (
II') (II'') (III') These chalcone derivatives (IV) or (■') are then reduced to convert the double bond in the hydrocarbon chain connecting both phenyl groups into a single bond (V ) or (V′), and then remove the protecting group to obtain the target compound (Vl): Reaction formula (B) (V[) In the above reaction, when a protecting group is added to the starting compound (IIL (I[[) The reaction to be introduced may be, for example, by reacting chloromethyl methyl ether and the starting compound at room temperature or with heating in the presence of diisopropylethylamine, but if necessary, the reaction may be carried out in the presence of a base such as dimethylaminopyridine. Alternatively, other protecting group introduction reactions can be used as appropriate.
また、原料化合物にジアルキル硫酸等アルキル化剤を反
応させるといったアルキル化反応を利用して化合物(n
’)、(II″)又は(■′)を製造してもよい。In addition, the compound (n
'), (II'') or (■') may be produced.
反応式(A)としては、保護基を導入したアセトフェノ
ンとベンズアルデヒドとを結合しうる反応であればすべ
ての反応を利用することができる。As reaction formula (A), any reaction can be used as long as it is capable of bonding acetophenone into which a protecting group has been introduced and benzaldehyde.
そのためには例えば、両者を縮合せしめる反応が広(利
用でき、酸塩基縮合剤等各種縮合剤を用いて常法にした
がって処理すればよい。縮合剤の例としては、水酸化カ
リウムあるいは水酸化ナトリウムなどがあげられ、これ
らの塩基を用いエタノール、ジメチルスルホキシド、そ
の他の単独又は混合有機溶媒中で双方の原料化合物を縮
合せしめればよい。反応終了後は酸を用いて中和し、カ
ルコン骨格を有する化合物(IV)、 (IV’)を得
るのである。For this purpose, for example, a reaction to condense the two can be carried out in a conventional manner using various condensing agents such as acid-base condensing agents. Examples of condensing agents include potassium hydroxide or sodium hydroxide. These bases can be used to condense both raw materials in ethanol, dimethyl sulfoxide, or other single or mixed organic solvents.After the reaction is complete, neutralize with acid to remove the chalcone skeleton. Compounds (IV) and (IV') having the following formula are obtained.
反応式(B)において、先ず還元反応は、例えば適当な
担体を併用したり、バラジューム炭素(ρd−c)、ラ
ネーニッケル触媒、白金黒や酸化白金等活性を高めた触
媒の存在下で水素を用いて還元する方法が用いられるが
、他の接触還元法も適宜利用できる。また、接触還元の
ほか他の還元方法も広く利用することができる。特に、
例えば水素を吸着させたPd−Cの酢酸エチル溶液を用
いる方法は本反応を行うのに好適な方法である。In reaction formula (B), the reduction reaction is first carried out using hydrogen in the presence of a catalyst with increased activity, such as a suitable carrier or a catalyst with increased activity such as baradium carbon (ρd-c), Raney nickel catalyst, platinum black, or platinum oxide. Although a catalytic reduction method is used, other catalytic reduction methods can also be used as appropriate. In addition to catalytic reduction, other reduction methods can also be widely used. especially,
For example, a method using an ethyl acetate solution of Pd-C on which hydrogen has been adsorbed is a suitable method for carrying out this reaction.
続いて保護基を除去して水酸基に戻すのであるが、それ
には(V)又はくV′)の有機溶媒溶液に塩酸メタノー
ルを添加する等、保護基の除去に常用される常法が適宜
利用される。Next, the protecting group is removed to return it to a hydroxyl group, and for this purpose, conventional methods commonly used for removing protecting groups, such as adding methanol hydrochloric acid to the organic solvent solution of (V) or (V'), are used as appropriate. be done.
2−位のOllを0−CIl□−COOC)13とする
には、すなわち、反応式(C)又は(C′)を行うには
、窒素雰囲気のもと、無水炭酸カリウムとヨウ化カリウ
ムの存在下又は水素化ナトリウムの存在下で、2−ブロ
ム酢酸メチルを作用せしめればよい。In order to change Oll at the 2-position to 0-CIl□-COOC)13, that is, to carry out reaction formula (C) or (C'), anhydrous potassium carbonate and potassium iodide are combined in a nitrogen atmosphere. Methyl 2-bromoacetate may be allowed to act in the presence of sodium hydride or in the presence of sodium hydride.
(来夏以下余白)
(■)
そして、上記した化合物(■)又は(■)は、前記した
方法によって保護基を外してOR’ を011にかえる
と、本発明に係る目的化合物が得られる。(Blank below next summer) (■) Then, when the protecting group is removed from the above-mentioned compound (■) or (■) by the method described above and OR' is changed to 011, the target compound according to the present invention can be obtained.
次いでこれを加水分解すれば、同じく目的化合物の1つ
である2位のエステル基−0−CHz−COOCIIi
を遊離カルボン酸基−〇−CIl□−COOI+とした
化合物が得られる。加水分解は、例えば、水酸化カリウ
ムあるいは水酸化ナトリウムをアルコール類などの有機
溶媒又は水に溶解した溶液を用いることが出来るが、こ
の方法のみに限定されることなく、酸又はアルカリを用
いる加水分解の常法が適宜利用される。If this is then hydrolyzed, the 2-position ester group -0-CHz-COOCIIi, which is also one of the target compounds, is obtained.
A compound having a free carboxylic acid group -〇-CIl□-COOI+ is obtained. For hydrolysis, for example, a solution of potassium hydroxide or sodium hydroxide dissolved in an organic solvent such as alcohol or water can be used, but the method is not limited to this method, and hydrolysis using an acid or an alkali can be used. The conventional method is used as appropriate.
また、目的化合物のアセトフェノン部分に置換基、例え
ば3位にイソペンチル基を導入した化合物は、次のよう
にして製造することができる。Further, a compound in which a substituent, for example, an isopentyl group is introduced into the acetophenone moiety of the target compound, can be produced as follows.
すなわち、次の反応式(D)で示される3位に3−メチ
ル−2ブテニル基を導入したヒドロキシ置換アセトフェ
ノンをアルキル化した後、これを前記したようにして還
元して、イソペンチル体を得る。That is, a hydroxy-substituted acetophenone having a 3-methyl-2-butenyl group introduced at the 3-position shown in the following reaction formula (D) is alkylated, and then reduced as described above to obtain an isopentyl compound.
このようにして得たイソペンチル体を、保護したベンズ
アルデヒドお縮合して、カルコン骨格を有する化合物を
製造し、アセトフェノンの2位のOHを0−CIl□−
COOCH3とし、この化合物を加水分解して0−C1
1z−GOORとした目的化合物(IX)を得ることが
できる。The isopentyl compound thus obtained is condensed with protected benzaldehyde to produce a compound having a chalcone skeleton, and the OH at the 2-position of acetophenone is 0-CIl□-
COOCH3 and this compound is hydrolyzed to 0-C1
The target compound (IX) designated as 1z-GOOR can be obtained.
0OH
(IX)
また、アセトフェノン部分とベンズアルデヒド部分とを
結合する炭素鎖を、既述したように1位オキソ置換体か
ら、ヒドロキシ置換体ないし非置換体とした本発明化合
物は次のようにして製造すればよい:
(来夏以下余白)
これらの反応は、いずれも還元反応であるが、還元剤の
種類や使用量をかえて還元の程度をコントロールするこ
とによって反応(E)又は(F)とすることができる。0OH (IX) In addition, the compounds of the present invention in which the carbon chain connecting the acetophenone moiety and the benzaldehyde moiety is changed from the 1-position oxo-substituted product to the hydroxy-substituted or unsubstituted product as described above can be produced as follows. (Next summer and below) All of these reactions are reduction reactions, but by controlling the degree of reduction by changing the type and amount of reducing agent used, reaction (E) or (F) can be achieved. can do.
例えば塩化アルミニウムと水素化アルミニウムリチウム
を所要量併用して反応(E)をすすめることができるし
、水素化アルミニウムリチウムを単用して反応(F)を
進行せしめることができる。For example, reaction (E) can be carried out by using aluminum chloride and lithium aluminum hydride together in required amounts, or reaction (F) can be carried out by using lithium aluminum hydride alone.
これらの反応終了後、既述した方法によって、各種の目
的化合物を自由に製造することができる。After completion of these reactions, various target compounds can be freely produced by the methods described above.
また、化合物(V)を反応式(C)によって化合物(■
)とした後、還元すれば、また別の目的化合物(X)が
得られる;
(■) (X)
つまり、反応(G)によれば、2位のメトキシカルボキ
シメトキシ基をヒドロキシエトキシ基に変えると同時に
、2個のフェニル基を結合する炭幸鎖の1位のオキソを
水酸基に変えることができるのである。In addition, compound (V) can be converted to compound (■
) and then reduction to obtain another target compound (X); (■) (X) In other words, according to reaction (G), the methoxycarboxymethoxy group at the 2-position is changed to a hydroxyethoxy group. At the same time, the oxo at position 1 of the carbonaceous chain that connects the two phenyl groups can be changed to a hydroxyl group.
以上、R3〜6.がOHの場合の化合物(I)の製造に
ついて述べたが、他の場合も同様にして製造することが
でき、それを後記する実施例においても具体的に明示す
るけれども、それと同様にして、更に以下のような化合
物も製造され、これらも本発明に包含される。Above, R3-6. Although we have described the production of compound (I) in which The following compounds have also been produced and are included in the present invention.
(1) 1− (2,4,6−トリス(メトキシメト
キシ)フェニル) −3−(3,4,5−1−リス(メ
トキシメトキシ)フェニル]−1−プロパノン(2)1
−(2−カルボキシメトキシ−3−ブチル−4,6−シ
メトキシフエニル)−3−(4−メトキシフェニル)プ
ロパン
(3)1−(2−メトキシメトキシ−3−イソペンチル
−4,6−シメトキシフエニル)−3−(4−メトキシ
フェニル)−1−プロパツール(4)1−(2−ヒドロ
キシ−4,6−シメトキシフエニル)−3−(4−メト
キシフェニル)−1−プロパノ−ル
一般式([)で示される化合物は、いずれも、医薬又は
医薬中間体として有用であって、特にすぐれた抗潰瘍作
用を有し、抗潰瘍剤として単用または併用される。また
必要ある場合には、他の抗潰瘍剤をはじめとする各種医
薬と併用することも可能である。(1) 1-(2,4,6-tris(methoxymethoxy)phenyl) -3-(3,4,5-1-lis(methoxymethoxy)phenyl)-1-propanone (2) 1
-(2-carboxymethoxy-3-butyl-4,6-cymethoxyphenyl)-3-(4-methoxyphenyl)propane (3) 1-(2-methoxymethoxy-3-isopentyl-4,6-cymethoxyphenyl) methoxyphenyl)-3-(4-methoxyphenyl)-1-propanol (4) 1-(2-hydroxy-4,6-simethoxyphenyl)-3-(4-methoxyphenyl)-1-propano All of the compounds represented by the general formula ([) are useful as medicines or pharmaceutical intermediates, have particularly excellent anti-ulcer effects, and are used alone or in combination as anti-ulcer agents. Furthermore, if necessary, it can also be used in combination with various medicines including other anti-ulcer agents.
以下、一般式(r)で示される化合物が抗潰瘍作用を有
することについて実験例を挙げて説明する。Hereinafter, the anti-ulcer effect of the compound represented by the general formula (r) will be explained with reference to experimental examples.
実験例1〜4
24時間絶食させた体重180〜200gのウィスター
(Wistar)系雄性ラット (1群10匹)に、式
Iの化合物ヲ0.5%CMC−Na(カルボキシメチル
セルロース・ナトリウム溶液)に懸濁して腹腔内または
経口投与し、30分後に150mM塩酸−60%エタノ
ール混液1dを経口投与した。150mM塩酸−60%
エタノール混液投与1時間後に開腹し、胃粘膜に生じた
1員傷部位の長さを粘膜損傷係数とし、コントロール群
と比較した。コントロール群には式Iの化合物を含まな
い0.5%CMC−Na溶液を腹腔内または経口投与し
た。次式により算出した抑制率を第1〜4表に示す。Experimental Examples 1 to 4 The compound of formula I was added to 0.5% CMC-Na (carboxymethylcellulose sodium solution) to male Wistar rats (10 rats per group) weighing 180 to 200 g that had been fasted for 24 hours. The suspension was administered intraperitoneally or orally, and 30 minutes later, 1 d of a mixture of 150 mM hydrochloric acid and 60% ethanol was administered orally. 150mM hydrochloric acid-60%
One hour after administration of the ethanol mixture, laparotomy was performed, and the length of the single-member wound site on the gastric mucosa was defined as the mucosal damage coefficient, and compared with the control group. A 0.5% CMC-Na solution containing no compound of formula I was administered intraperitoneally or orally to the control group. Tables 1 to 4 show the inhibition rates calculated using the following formula.
ハ
A:コントロール群の値
B:八■の化合物投与群の値
(1)経口投与による抗潰瘍試験結果
(投与量:30mg/kg)
第 1 表
(2)経口投与による抗潰瘍試験結果
(投与量:30mg/kg)
(3)経口投与による抗潰瘍試験結果
(1り与呈: 100mg/kg)
第3表
(4) 1m腔内投与による抗潰瘍試験結果(投与量:
100mg/kg)
第4表
以上の実験例より明らかなように式Iの化合物は、優れ
た抗潰瘍作用を示す。A: Value of control group B: Value of compound administration group (1) Results of anti-ulcer test by oral administration (dose: 30 mg/kg) Table 1 (2) Results of anti-ulcer test by oral administration (administration Amount: 30 mg/kg) (3) Results of anti-ulcer test by oral administration (1 dose: 100 mg/kg) Table 3 (4) Results of anti-ulcer test by 1 m intracavitary administration (dose:
100mg/kg) As is clear from the experimental examples in Table 4 and above, the compound of formula I exhibits excellent anti-ulcer activity.
従って、このカルコン誘導体を有効成分とする本発明の
薬剤は、優れた抗潰瘍剤である。Therefore, the drug of the present invention containing this chalcone derivative as an active ingredient is an excellent anti-ulcer agent.
更に、式Iの化合物をddY系雄性マウスにIg/kg
経口投与したところ死亡例は認められなかった。Furthermore, the compound of formula I was administered to ddY male mice at Ig/kg.
No deaths were observed after oral administration.
このように、式■の化合物は毒性が低く、安全性の高い
ものである。Thus, the compound of formula (1) has low toxicity and high safety.
次に、本発明の化合物の投与量および製剤化について説
明する。Next, the dosage and formulation of the compound of the present invention will be explained.
−m弐の化合物はそのまま、あるいは慣用の製剤担体と
共に動物および人に投与することができる。投与形態と
しては、特に限定がなく、必要に応じ適宜選択して使用
され、錠剤、カプセル剤、顆粒剤、細粒剤、散剤等の経
口剤、注射剤、坐剤等の非経口剤が挙げられる。-m2 compounds can be administered to animals and humans as such or together with conventional pharmaceutical carriers. The dosage form is not particularly limited and may be selected and used as necessary, and may include oral dosage forms such as tablets, capsules, granules, fine granules, and powders, and parenteral dosage forms such as injections and suppositories. It will be done.
経口剤として所期の効果を発揮するためには、患者の年
令、体重、疾患の程度により異なるが、通常成人で一般
式の化合物の重量として100〜900mgを、1日数
回に分けての服用が適当と思われる。In order to achieve the desired effect as an oral agent, an adult dose of 100 to 900 mg of the compound of the general formula should be administered in divided doses several times a day, although this will vary depending on the age, weight, and severity of the disease of the patient. It seems appropriate to take it.
錠剤、カプセル剤、顆粒剤等の経口剤は、例えばデンプ
ン、乳糖、白糖、マンニット、カルボキシメチルセルロ
ース、コーンスターチ、無機塩類等を用いて常法に従っ
て製造される。Oral preparations such as tablets, capsules, and granules are manufactured according to conventional methods using, for example, starch, lactose, sucrose, mannitol, carboxymethylcellulose, cornstarch, inorganic salts, and the like.
この種の製剤には、適宜前記賦形剤の他に、結合剤、崩
壊剤、界面活性剤、滑沢剤、流動性促進剤、矯味剤、着
色剤、香料等を使用することができる。それぞれの具体
例は以下に示す如くである。In addition to the excipients mentioned above, binders, disintegrants, surfactants, lubricants, fluidity promoters, flavoring agents, coloring agents, fragrances, and the like can be used in this type of preparation as appropriate. Specific examples of each are shown below.
[結合剤]
デンプン、デキストリン、アラビアゴム末、ゼラチン、
ヒドロキシプロピルスターチ、メチルセルロース、カル
ボキシメチルセルロースナトリウム、ヒドロキシプロピ
ルセルロース、結晶セルロース、エチルセルロース、ポ
リビニルピロリドン、マクロゴール。[Binder] Starch, dextrin, gum arabic powder, gelatin,
Hydroxypropyl starch, methylcellulose, sodium carboxymethylcellulose, hydroxypropylcellulose, crystalline cellulose, ethylcellulose, polyvinylpyrrolidone, macrogol.
[崩壊剤1
デンプン、ヒドロキシプロピルスターチ、カルボキシメ
チルセルロースナトリウム、カルボキシメチルセルロー
スカルシウム、カルボキシメチルセルロース、低置換ヒ
ドロキシプロピル七ルロース。[Disintegrant 1 Starch, hydroxypropyl starch, carboxymethylcellulose sodium, carboxymethylcellulose calcium, carboxymethylcellulose, low substituted hydroxypropyl heptylulose.
[界面活性剤]
ラウリル硫酸ナトリウム、大豆レシチン、ショ糖脂肪酸
エステル、ポリソルベート80゜[滑沢剤1
タルク、ロウ類、水素添加植物油、ショ糖脂肪酸エステ
ル、ステアリン酸マグネシウム、ステアリン酸カルシウ
ム、ステアリン酸アルミニウム、ポリエチレングリコー
ル。[Surfactant] Sodium lauryl sulfate, soy lecithin, sucrose fatty acid ester, polysorbate 80° [Lubricant 1 Talc, waxes, hydrogenated vegetable oil, sucrose fatty acid ester, magnesium stearate, calcium stearate, aluminum stearate, Polyethylene glycol.
[流動性促進剤]
軽質無水ケイ酸、乾燥水酸化アルミニウムゲル、合成ケ
イ酸アルミニウム、ケイ酸マグネシウム。[Fluidity promoter] Light anhydrous silicic acid, dry aluminum hydroxide gel, synthetic aluminum silicate, magnesium silicate.
また、一般弐の化合物は、懸濁液、エマルジョン剤、シ
ロップ剤、エリキシル剤としても投与す゛ることができ
、これらの各種剤形には矯味矯臭剤、着色剤を含有して
もよい。Furthermore, the compound of General 2 can be administered as a suspension, emulsion, syrup, or elixir, and these various dosage forms may contain flavoring agents and coloring agents.
非経口剤として所期の効果を発揮するためには、患者の
年令、体重、疾患の程度により異なるが、通常成人で一
般式の化合物の重量として1日0.1〜30mgまでの
静注、点滴静注、皮下注射、筋肉注射が適当と思われる
。In order to exert the desired effect as a parenteral agent, it is usually necessary to administer 0.1 to 30 mg of the compound of the general formula per day intravenously for adults, although this will vary depending on the age, weight, and severity of the disease of the patient. , intravenous drip, subcutaneous injection, and intramuscular injection are considered appropriate.
この非経口剤は常法に従って製造され、希釈剤として一
般に注射用蒸留水、生理食塩水、ブトウキ13水溶液、
注射用植物油、ゴマ油、ラッカセイ油、ダイズ油、トウ
モロコシ油、プロピレングリコール、ポリエチレングリ
コール等を用いることができる。さらに必要に応じて、
殺菌剤、防腐剤、安定剤を加えてもよい。また、この非
経口ff1Jは安定性の点から、バイアル等に充填後冷
凍し、通常の凍結乾燥技術により水分を除去し、使用直
前に凍結乾燥物から液剤を再調製することもできる。更
に、必要に応じて適宜、等張化剤、安定剤、防腐剤、無
痛化剤等を加えても良い。This parenteral preparation is manufactured according to a conventional method, and diluents generally include distilled water for injection, physiological saline, Butoki 13 aqueous solution,
Vegetable oils for injection, sesame oil, peanut oil, soybean oil, corn oil, propylene glycol, polyethylene glycol, etc. can be used. Furthermore, if necessary,
Bactericides, preservatives and stabilizers may also be added. In addition, from the viewpoint of stability, this parenteral ff1J can also be filled into a vial or the like, frozen, water removed by ordinary freeze-drying techniques, and a liquid preparation prepared from the freeze-dried product immediately before use. Furthermore, isotonizing agents, stabilizers, preservatives, soothing agents, etc. may be added as appropriate.
その他の非経口剤としては、外用液剤、軟膏等の塗布剤
、直腸内投与のための坐剤等が挙げられ、常法に従って
製造される。Other parenteral preparations include liquid preparations for external use, liniments such as ointments, suppositories for rectal administration, and the like, which are manufactured according to conventional methods.
本発明に係る化合物の合成については実施例、また薬剤
の調製については、調剤例によって本発明を具体的且つ
詳細に説明するが、本発明はこれらに限定されるもので
はない。The present invention will be explained specifically and in detail by Examples regarding the synthesis of the compounds according to the present invention, and Preparation Examples regarding the preparation of drugs, but the present invention is not limited thereto.
実施例1
l−(2,4,6−1−リヒドロキシフェニル)−3−
(3,4,5−)リヒドロキシフェニル)−1−プロパ
ノン
(1)2’、4’、6’−トリス(メトキシメトキシ)
アセトフェノン
2’、4’、6’−)リヒドロキシアセトフェノンとジ
メチルアミノピリジンのジメチルホルムアミド溶液にジ
イソプロピルエチルアミンを、50゛cに加温しながら
滴下し、撹拌した。次いで反応混合物に加水した後、ジ
エチルエーテルで抽出し、溶媒を留去して、2’、4’
、6’−1−リス(メトキシメトキシ)アセトフェノン
(収率65%)を得た。Example 1 l-(2,4,6-1-lihydroxyphenyl)-3-
(3,4,5-)lihydroxyphenyl)-1-propanone (1) 2',4',6'-tris(methoxymethoxy)
Acetophenone (2', 4', 6'-) diisopropylethylamine was added dropwise to a dimethylformamide solution of hydroxyacetophenone and dimethylaminopyridine while heating to 50°C, and the mixture was stirred. Next, the reaction mixture was added with water, extracted with diethyl ether, the solvent was distilled off, and 2', 4'
, 6'-1-lis(methoxymethoxy)acetophenone (yield 65%) was obtained.
分子式:C,、+12゜O,(300)融点: 39.
5〜40.5”C
赤外線吸収スペクトルν□xcm−’(KBr) :2
968、 1710. 1606. 1246. 12
32. 1220゜1154、1114.1078.1
046.1024.924゜908、818
プロトン核磁気共鳴スペクトル(200MZ)δppm
。Molecular formula: C, +12°O, (300) Melting point: 39.
5-40.5"C Infrared absorption spectrum ν□xcm-' (KBr): 2
968, 1710. 1606. 1246. 12
32. 1220°1154, 1114.1078.1
046.1024.924°908,818 Proton nuclear magnetic resonance spectrum (200MZ) δppm
.
J oz、 CDCh :
62.49(3■、S)、δ3.,16(S)、63.
47(S)。J oz, CDCh: 62.49 (3■, S), δ3. , 16(S), 63.
47(S).
65.14(S)、65.15(S)、δ6.51 (
2+1.5)(2) 3.4.5−トリス(メトキシ
メトキシ)ベンズアルデヒド
3、4.5−トリヒドロキシヘンズアルデヒドの一水和
物
I’l1
1.0g(5,8ミリモル)を原料として用い、この化
合物とジメチルアミノピリジン0.1gのT旺溶ン夜1
5m1にジイソプロピルエチルアミン撹拌した。水冷下
で混合溶液にクロロメチルメチルエーテル6、5mlを
滴下し約30分間撹拌したのちに室温で更に終夜撹拌し
た。反応混合液に水を加え、ジエチルエーテルで抽出し
、水洗、乾燥(無水硫酸ナトリウム)したのち溶媒を留
去した。残留物にヘキサンを加え、冷凍庫で固化させた
のちに、冷ジエチルエーテル−ヘキサン系で洗浄し、濾
取したところ標記化合物を1.16g(70%)得た。65.14 (S), 65.15 (S), δ6.51 (
2+1.5)(2) 3.4.5-tris(methoxymethoxy)benzaldehyde 3,4.5-trihydroxyhenzaldehyde monohydrate I'l1 1.0 g (5.8 mmol) was used as a raw material. , dissolve this compound and 0.1 g of dimethylaminopyridine at night 1.
Diisopropylethylamine was stirred into 5ml. While cooling with water, 6.5 ml of chloromethyl methyl ether was added dropwise to the mixed solution, stirred for about 30 minutes, and then further stirred overnight at room temperature. Water was added to the reaction mixture, extracted with diethyl ether, washed with water, dried (anhydrous sodium sulfate), and then the solvent was distilled off. Hexane was added to the residue, which was solidified in a freezer, washed with cold diethyl ether-hexane system, and collected by filtration to obtain 1.16 g (70%) of the title compound.
分子式: C+x11+sOr<286)融点:53.
5〜54.5°C
赤外線吸収スペクトルv 、1.Xcm− ’ (KB
r) :2932、 1694, 1494,
1454, 1440, 1382。Molecular formula: C+x11+sOr<286) Melting point: 53.
5-54.5°C Infrared absorption spectrum v, 1. Xcm-' (KB
r) :2932, 1694, 1494,
1454, 1440, 1382.
1322、1300.1162.1152,1138,
1112。1322, 1300.1162.1152, 1138,
1112.
1058、1050.942
プロトン核磁気共鳴スペクトル(200 MZ)δpp
m。1058, 1050.942 Proton nuclear magnetic resonance spectrum (200 MZ) δpp
m.
J uz. (CDCh) :
63、69(6+1,S) 、 63.80(3+1
,S) 、 δ5。42(21+. S) 、 δ
5.45(411.S) 、 δ7.56(2H,S
)(3) 2’, 3, 4. 4’, 5, 6.
6’−へキサキス(メトキシメトキシ)カルコン
(1)で得た化合物1.0gと(2)で得た化合物1、
0gのエタノールiotIi溶液に、飽和水酸化カリウ
ムのエタノール溶液8m#を加え室温で終夜撹拌した。Juz. (CDCh): 63, 69 (6+1, S), 63.80 (3+1
,S), δ5.42(21+.S), δ
5.45 (411.S), δ7.56 (2H,S
)(3) 2', 3, 4. 4', 5, 6.
1.0 g of the compound obtained from 6'-hexakis(methoxymethoxy)chalcone (1) and compound 1 obtained from (2),
To 0 g of ethanol iotIi solution, 8 m# of saturated potassium hydroxide in ethanol was added and stirred at room temperature overnight.
反応混合物を大量の水に注ぎ、希塩酸を用いて、中和し
たのち、析出した固体を濾取した。濾別した固体を酢酸
エチルに溶解し、水洗、乾燥したのちに溶媒を留去した
。濃縮物を酢酸エチル−ジエチルエーテル−ヘキサン系
で結晶化したところ、淡黄色針状として標記化合物を1
.60g (85%)得た。The reaction mixture was poured into a large amount of water, neutralized using dilute hydrochloric acid, and the precipitated solid was collected by filtration. The filtered solid was dissolved in ethyl acetate, washed with water, dried, and then the solvent was distilled off. When the concentrate was crystallized from ethyl acetate-diethyl ether-hexane system, the title compound was crystallized as pale yellow needles.
.. 60g (85%) obtained.
分子式: Czyl1360+ * (568)融点:
105.0〜106.0°C
赤外線吸収スペクトルI’ maxCm− ’ (KB
r) :1650、 1608, 1156. 1
110, 1080, 1048。Molecular formula: Czyl1360+ * (568) Melting point:
105.0~106.0°C Infrared absorption spectrum I'maxCm-' (KB
r): 1650, 1608, 1156. 1
110, 1080, 1048.
1018、 962
プロトン核磁気共鳴スペクトル(200 MZ)δpp
m。1018, 962 Proton nuclear magnetic resonance spectrum (200 MZ) δpp
m.
’ 82. (CDCI3) ;
63、40(6H,S)、 δ3.50(6H,S)
、 δ3.52(311,S)、 63.61 (
3H,S) 、 δ5. 11 (4+1, S)
。'82. (CDCI3); 63, 40 (6H, S), δ3.50 (6H, S)
, δ3.52 (311,S), 63.61 (
3H,S), δ5. 11 (4+1, S)
.
65、 17 (2H, S) 、 δ5.19,
5.20(S,6+1)。65, 17 (2H, S), δ5.19,
5.20 (S, 6+1).
66、57(2H,S)、 66、87(In,a,
J=16.9)。66, 57 (2H, S), 66, 87 (In, a,
J=16.9).
67、04(LH,S)、 δ7.23(ill,d
,J・15.9)(4) 1− (2, 4. 6
−)リス(メトキシメトキシ)フェニル) −3 −
(3,4.5 − トリス(メトキシメトキシ)フェニ
ル]−1−プロパノンMOM
予め水素を吸着させたPd−C 2.6gの酢酸エチル
50ml溶液に(3)で得た化合物517.5gの酢酸
エチル200d溶液を加え、強く撹拌しながら、更に水
素を吸着させた。吸着終了後、セライトを用いて、Pd
−Cを除き次に溶媒を留去した。濃縮物を酢酸エチル(
少量)−ジエチルエーテル−ヘキサン系で結晶化したと
ころ白色の固体として標記化合物を17、1g(夕10
0%)得た。67,04(LH,S), δ7.23(ill,d
, J・15.9) (4) 1- (2, 4.6
-) lis(methoxymethoxy)phenyl) -3 -
(3,4.5-tris(methoxymethoxy)phenyl]-1-propanone MOM Add 517.5 g of the compound obtained in (3) to 50 ml of ethyl acetate solution of 2.6 g of Pd-C to which hydrogen has been adsorbed in advance. 200d solution was added, and while stirring strongly, hydrogen was further adsorbed.After the adsorption was completed, Pd was added using Celite.
-C was removed and then the solvent was distilled off. The concentrate was diluted with ethyl acetate (
When crystallized from a small amount)-diethyl ether-hexane system, 17.1 g of the title compound was obtained as a white solid (at 10 p.m.
0%) obtained.
分子式: CzJzsO+3(570)融点: 55.
0〜55.5°C
赤外線吸収スペクトルνmaxcm−’(KBr) :
1696、 1608, 1594, 1156, 1
110, 1080。Molecular formula: CzJzsO+3 (570) Melting point: 55.
0 to 55.5°C Infrared absorption spectrum νmaxcm-' (KBr):
1696, 1608, 1594, 1156, 1
110, 1080.
1052、 1018. 968, 920プロトン核
磁気共鳴スペクトル(200 MZ)δppm。1052, 1018. 968, 920 proton nuclear magnetic resonance spectrum (200 MZ) δppm.
J 82. (CDCI:l) :
62、9〜3.2(41!,m)、δ3.43, 3.
47, 3.49。J82. (CDCI:l): 62, 9-3.2 (41!, m), δ3.43, 3.
47, 3.49.
3.61.δ5.10. 5.11. 5.14. 5
.17.δ6.50(211,S) 、 66.70
(2H,5)(5) 1−(2,4,6−1−リヒド
ロキシフェニル)−3−(3,4,5−)リヒドロキジ
フェニル)−1−プロパノン
アルゴン雰囲気下、(4)で得た化合物10.0gのメ
タノール溶液100−に塩酸−メタノールを80m1滴
下し室温で2時間30分撹拌した。反応終了後、反応混
合物に水を加え、ジエチルエーテルで抽出し、水洗、乾
燥(無水硫酸ナトリウム)したのちに溶媒を留去した。3.61. δ5.10. 5.11. 5.14. 5
.. 17. δ6.50(211,S), 66.70
(2H,5) (5) 1-(2,4,6-1-lihydroxyphenyl)-3-(3,4,5-)lihydroxydiphenyl)-1-propanone under argon atmosphere, (4) 80 ml of hydrochloric acid-methanol was added dropwise to a methanol solution of 10.0 g of the compound obtained in step 100, and the mixture was stirred at room temperature for 2 hours and 30 minutes. After the reaction was completed, water was added to the reaction mixture, extracted with diethyl ether, washed with water, dried (anhydrous sodium sulfate), and then the solvent was distilled off.
析出した固体を酢酸エチル−ジエチルエーテルで洗浄し
たのちに濾取したところ、淡黄色の粉体として標記化合
物を3.6g(62%)得た。The precipitated solid was washed with ethyl acetate-diethyl ether and then collected by filtration to obtain 3.6 g (62%) of the title compound as a pale yellow powder.
分子式: C+sll+40’t(306)融点: 2
71〜273(dec、)
赤外線吸収スペクトルν□xcm−’(KBr) :3
500、3428.3272.1644.1618.1
596゜プロトン核磁気共鳴スペクトル(200MZ)
δppm。Molecular formula: C+sll+40't (306) Melting point: 2
71-273 (dec,) Infrared absorption spectrum ν□xcm-' (KBr): 3
500, 3428.3272.1644.1618.1
596° proton nuclear magnetic resonance spectrum (200MZ)
δppm.
J H2,(八ceton−d) :δ2.77(
211,m)、 63.32(211,m)、 δ
5.94(2+1.S)、 δ6.32(2+1.S
)マススペクトルm/z(χ):
302(M’ 、20)、 180(11)、 168
(18)、 153(100)、 126(75)
実施例2
l−(2,4,6−)リヒドロキシフェニル)−3−(
2,3,4−1−リヒドロキシフェニル)−1−プロパ
ノン
(1)2,3.4−トリス (メトキシメトキシ)ベン
ズアルデヒド
2.3.4−トリヒドロキシベンズアルデヒド20.O
gとジメチルアミノピリジン2.0gのジメチルホルム
アミド溶液200dに、ジイソプロピルエチルアミン1
68 dを加え、撹拌した。水冷下で反応混合物にクロ
ロメチルメチルエーテルを741n1滴下し、30分間
撹拌したのち室温に戻し更に5時間撹拌した。反応終了
後、反応混合物に水を加え、ジエチルエーテルで抽出し
、水洗、乾燥(無水硫酸ナトリウム)したのちに溶媒を
留去した。残留物を冷凍庫で固化させ冷ヘキサンで洗浄
し濾取したところ、標記化合物を30.6g(82%)
得た。J H2, (8ceton-d): δ2.77(
211, m), 63.32 (211, m), δ
5.94 (2+1.S), δ6.32 (2+1.S
) Mass spectrum m/z (χ): 302 (M', 20), 180 (11), 168
(18), 153(100), 126(75) Example 2 l-(2,4,6-)lihydroxyphenyl)-3-(
2,3,4-1-Lihydroxyphenyl)-1-propanone (1) 2,3,4-Tris (methoxymethoxy)benzaldehyde 2.3,4-Trihydroxybenzaldehyde 20. O
To 200 d of a dimethylformamide solution containing 1 g and 2.0 g of dimethylaminopyridine, 1
68 d was added and stirred. 741n1 of chloromethyl methyl ether was added dropwise to the reaction mixture under water cooling, and after stirring for 30 minutes, the mixture was returned to room temperature and further stirred for 5 hours. After the reaction was completed, water was added to the reaction mixture, extracted with diethyl ether, washed with water, dried (anhydrous sodium sulfate), and then the solvent was distilled off. The residue was solidified in the freezer, washed with cold hexane, and collected by filtration, yielding 30.6 g (82%) of the title compound.
Obtained.
分子式: C+zll+5Ot(286)融点:<30
°C
赤外線吸収スペクトルl’ saxCm−’ (KBr
) :2904、1’6B4.1594.1494.1
454.1384゜1276、1156.108B、
1034.994.956.922プロトン核磁気共鳴
スペクトル(200?’lZ)δppm。Molecular formula: C+zll+5Ot (286) Melting point: <30
°C Infrared absorption spectrum l'saxCm-' (KBr
) :2904, 1'6B4.1594.1494.1
454.1384°1276, 1156.108B,
1034.994.956.922 Proton nuclear magnetic resonance spectrum (200?'lZ) δppm.
J oz、 (CDCh) :
63.51(311,5)、 δ3.57(311,
S)、 δ3.62(3)1 、 S) 、 65
.15(2+1.S) 、 65.27(2H,S)
。J oz, (CDCh): 63.51 (311,5), δ3.57 (311,
S), δ3.62(3)1, S), 65
.. 15 (2+1.S), 65.27 (2H,S)
.
65、28 (211、S) 、 67.04(It
(、d、J・8.8)。65, 28 (211, S), 67.04 (It
(, d, J.8.8).
δ7.61(111,d、J・8.8)、 δ10.
29(IH,S) 。δ7.61 (111, d, J・8.8), δ10.
29 (IH, S).
(2)2’−ヒドロキシ−4’、6’−ビス(メトキシ
メトキシ)アセトフェノン
2’、4’、6’−トリヒドロキシアセトフェノン2.
0gのT HF 溶液10−にジイソプロピルエチルア
ミン8、3 yklを加えた。反応混合液を一20°C
に冷却したのちクロロメチルメチルエーテルを3.61
−加え更に30分間撹拌した。反応混合液を室温で2時
間撹拌したのちに、水を加え、ジエチルエーテルで抽出
し、水洗、乾燥(無水硫酸ナトリウム)、濃縮した。濃
縮物にジエチルエーテルとヘキサンを加え冷凍庫で結晶
化したところ、白色の粉末として標記化合物を2.30
g (75%)得た。(2) 2'-hydroxy-4',6'-bis(methoxymethoxy)acetophenone 2',4',6'-trihydroxyacetophenone2.
8,3 ykl of diisopropylethylamine was added to 0 g of 10-g THF solution. Heat the reaction mixture to -20°C.
After cooling to 3.61 chloromethyl methyl ether,
- and stirred for an additional 30 minutes. After stirring the reaction mixture at room temperature for 2 hours, water was added, extracted with diethyl ether, washed with water, dried (anhydrous sodium sulfate), and concentrated. When diethyl ether and hexane were added to the concentrate and crystallized in the freezer, the title compound was obtained as a white powder at 2.30%
g (75%) was obtained.
分子式: C+2H+10a(25G)融点: 47.
0〜48,0°C
赤外線吸収スペクトルl’ mmxCm−’ (KBr
) :1622、 1594. 1270. 1222
.1208. 1166゜1152. 1080. 1
066、 1028. 946プロトン核磁気共鳴スペ
クトル(200MZ)δppm。Molecular formula: C+2H+10a (25G) Melting point: 47.
0~48,0°C Infrared absorption spectrum l'mmxCm-' (KBr
) :1622, 1594. 1270. 1222
.. 1208. 1166°1152. 1080. 1
066, 1028. 946 proton nuclear magnetic resonance spectrum (200MZ) δppm.
J nz、 (CDCl2) :
δ2.65(3H,S) 、 δ3.47(3H,S
) 、 δ3.52(3)1.S)、 δ5.17
(211,S) 、 65.25(2+1.S) 。J nz, (CDCl2): δ2.65(3H,S), δ3.47(3H,S
), δ3.52(3)1. S), δ5.17
(211,S), 65.25(2+1.S).
66.24(211,5)
(3)2’−ヒドロキシ−2,3,4,4’、 6’−
ペンタキス(メトキシメトキシ)カルコン
(2)で得た化合物10.0gと(1)で得た化合物1
1.2gのエタノール溶液100−に飽和水酸化カリウ
ム−エタノール溶液80−を加え室温で終夜撹拌した。66.24(211,5) (3) 2'-hydroxy-2,3,4,4', 6'-
10.0 g of the compound obtained from pentakis(methoxymethoxy)chalcone (2) and compound 1 obtained from (1)
To 1.2 g of 100 g of ethanol solution was added 80 g of saturated potassium hydroxide-ethanol solution, and the mixture was stirred at room temperature overnight.
反応混合物を大量の水に注ぎ、希塩酸を用いて、中和し
たのち、酢酸エチルで抽出し、水洗、乾燥(無水硫酸ナ
トリウム)したのちに溶媒を留去した。濃縮物をシリカ
ゲルクロマトグラフィー(溶離剤 酢酸エチル:ヘキサ
ン−1:2フラクシヨン20〜33.1本=300ml
、φ−100mm、H−260mm)で分離精製したと
ころ、赤橙色の油状物として標記化合物を18.1g(
89%)得た。The reaction mixture was poured into a large amount of water, neutralized using dilute hydrochloric acid, extracted with ethyl acetate, washed with water, dried (anhydrous sodium sulfate), and then the solvent was distilled off. The concentrate was subjected to silica gel chromatography (eluent: 20 to 33.1 fractions of ethyl acetate:hexane-1:2 = 300 ml).
, φ-100mm, H-260mm), 18.1g (18.1g) of the title compound was obtained as a red-orange oil.
89%).
分子式:(,5ll=□OI□(524)融点: 65
.5〜67°C
赤外線吸収スペクトルV maxCm−’ (KBr)
:1632、1586.1562.1494.127
8.1212゜1158、1090.932
プロトン核磁気共鳴スペクトル(200MZ)δppm
。Molecular formula: (,5ll=□OI□(524) Melting point: 65
.. 5-67°C Infrared absorption spectrum V maxCm-' (KBr)
:1632, 1586.1562.1494.127
8.1212°1158, 1090.932 Proton nuclear magnetic resonance spectrum (200MZ) δppm
.
J 112. (CDCIff) :
63、48 (38、S) 、 63.51 (3H
,S) 、 δ3.53(311,S)、 δ3.
62(311,S)、 δ3.63(311,S)
。J 112. (CDCIff): 63, 48 (38, S), 63.51 (3H
,S), δ3.53(311,S), δ3.
62 (311, S), δ3.63 (311, S)
.
65.15(211,S)、 δ5.18(2)1.
S) 、 δ5.21(2+1. S) 、 65
.24(2+1.S) 、 65.28(2+1.
S) 。65.15 (211, S), δ5.18 (2) 1.
S), δ5.21(2+1.S), 65
.. 24(2+1.S), 65.28(2+1.S)
S).
66.26(ILd、J=2.2) 、66.3(IH
,d、J・2.2)。66.26 (ILd, J=2.2), 66.3 (IH
, d, J・2.2).
66.99(ill、d、J=8.8) 、δ7.38
(ill、d、J=8.8)。66.99 (ill, d, J=8.8), δ7.38
(ill, d, J=8.8).
δ7.86(1)1.d、J=15.6)、 δ8.
16(1)1.d、J・15.6)
(4)1−(2−ヒドロキシ−4,6−ビス(メトキシ
メトキシ)フェニル) −3−(2,3,4−トリス(
メトキシメトキシ)フェニル〕−1−プロパノン
予め水素を吸着させたPd−C(5%)3.0gの酢酸
エチル70Tnl溶液に(3)で得た化合物18.0
gの酢酸エチル390−溶液を加え、強く撹拌しながら
、更に水素を吸着させた。吸着終了後、セライトを用い
て、Pd−Cを除き次に溶媒を留去した。濃縮物を減圧
乾燥したところ、無色透明の油状物として標記化合物を
18.34g(々100%)得た。δ7.86(1)1. d, J=15.6), δ8.
16(1)1. d, J・15.6) (4) 1-(2-hydroxy-4,6-bis(methoxymethoxy)phenyl) -3-(2,3,4-tris(
methoxymethoxy)phenyl]-1-propanone Add 18.0 g of the compound obtained in (3) to a solution of 3.0 g of Pd-C (5%) on which hydrogen has been adsorbed in 70 Tnl of ethyl acetate.
A solution of 390g of ethyl acetate was added thereto, and hydrogen was further adsorbed while stirring vigorously. After the adsorption was completed, Pd-C was removed using Celite, and then the solvent was distilled off. The concentrate was dried under reduced pressure to obtain 18.34 g (100%) of the title compound as a colorless and transparent oil.
分子式: CzsHtnO+t(526)無色油状物
赤外線吸収スペクトルν□Xcm−’ (Neat)
:1622、1602.1162.1152.1082
.105B。Molecular formula: CzsHtnO+t (526) Colorless oil Infrared absorption spectrum ν□Xcm-' (Neat)
:1622, 1602.1162.1152.1082
.. 105B.
1042、1022.924
プロトン核磁気共鳴スペクトル(200MZ)δppm
。1042, 1022.924 Proton nuclear magnetic resonance spectrum (200MZ) δppm
.
J H2,(CDC1z) :
53.06(2H,m)、δ3.37(2)1.m)、
δ3.45Cs>。J H2, (CDC1z): 53.06 (2H, m), δ3.37 (2) 1. m),
δ3.45Cs>.
63.47(S)、δ3.51 (S) 、δ3.54
(S) 、δ3.6゜(S)、65.12(S)、δ
5.14 (S) 、δ5.18(S)、δ5、22
(S) 、66.26(111,d、J・5.4)、6
6.27(IH。63.47 (S), δ3.51 (S), δ3.54
(S), δ3.6゜(S), 65.12(S), δ
5.14 (S), δ5.18 (S), δ5, 22
(S), 66.26 (111, d, J・5.4), 6
6.27 (IH.
a、+=5.4)、66.89(2+1.d、J・0.
4)(5) 1−(2,4,6−1−リヒドロキシフ
ェニル)−3−(2,3,4−トリヒドロキシフェニル
)−1−プロパノン
アルゴン雰囲気下、(4)で得た化合物4.6gのメタ
ノール80m/溶液に塩酸−メタノール50mfを加え
、室温で1時間30分撹拌した。反応混合物に多量の水
を加え酢酸エチルで抽出し、水洗、乾燥(無水硫酸ナト
リウム)したのちに溶媒を留去した。濃縮物をLH−2
0で分離精製したのちにアセトン−エーテル−ヘキサン
系で結晶化したところ、白色粉末として標記化合物を1
.36g(51%)得た。a, +=5.4), 66.89 (2+1.d, J・0.
4) (5) 1-(2,4,6-1-lihydroxyphenyl)-3-(2,3,4-trihydroxyphenyl)-1-propanone Compound obtained in (4) under argon atmosphere Hydrochloric acid-methanol 50 mf was added to 4.6 g of methanol 80 m/solution, and the mixture was stirred at room temperature for 1 hour and 30 minutes. A large amount of water was added to the reaction mixture, extracted with ethyl acetate, washed with water, dried (anhydrous sodium sulfate), and then the solvent was distilled off. Concentrate LH-2
After separation and purification with 0, the title compound was crystallized with acetone-ether-hexane system, and the title compound was obtained as a white powder with 1
.. 36g (51%) was obtained.
分子式:C,sit□0.(306)
融点: 224.0〜225.5Cdec、)赤外線吸
収スペクトルν□xcm−’(KBr) :3276、
1640.1616.1570.1524.1472゜
1304、1284.1256.1204.1168プ
ロトン核磁気共鳴スペクトル(200MZ)δppm。Molecular formula: C, sit□0. (306) Melting point: 224.0-225.5Cdec,) Infrared absorption spectrum ν□xcm-' (KBr): 3276,
1640.1616.1570.1524.1472°1304, 1284.1256.1204.1168 Proton nuclear magnetic resonance spectrum (200MZ) δppm.
J IIz、 (Aceton−d) :62.90(
28,m)、 63.39(211,m) 、 δ
5.93(211、S) 、 66.32(III、
d、J・8.3)、 66.51(III、d、J・
8.3)
マススペクトルm/z(χ):
180(42)、 138(100)、 126(79
)実施例3
l−(2−カルボキシメトキシ−4,6−シメトキシー
3−イソペンチルフェニル)−3−(4−メトキシフェ
ニル)プロパン
(1)1−(2−ヒドロキシ−4,6−ジメトキシ−3
−イソペンチルフェニル−3−(4−メトキシフェニル
)プロパン
■−(2−ヒドロキシ−4,6−シメトキシー3−イソ
ペンチルフェニル)−3−(4−メトキシフェニル)−
1−プロパノン
0゜20gのテトラヒドロフラン(3mZ)溶液に水冷
下で0.17gの塩化アルミニウムと0.04gの水素
化アルミニウムリチウムを注意しながら加え、60分間
加熱還流した。続いて反応混合物に、酢酸エチルと希塩
酸を加えエーテル抽出し、水洗、乾燥(無水硫酸ナトリ
ウム)したのちに溶媒を留去した。残留物をシリカゲル
カラムクロマトグラフィ(Merck 9385、φ=
25n+n+、 H=220 mm、フラクション2〜
5150mf)で分離精製したところ、黄色の油状物と
して標記の化合物を0.17g(87%)得た。J IIz, (Aceton-d): 62.90 (
28, m), 63.39 (211, m), δ
5.93 (211, S), 66.32 (III,
d, J・8.3), 66.51 (III, d, J・
8.3) Mass spectrum m/z (χ): 180 (42), 138 (100), 126 (79
) Example 3 l-(2-carboxymethoxy-4,6-simethoxy-3-isopentylphenyl)-3-(4-methoxyphenyl)propane (1) 1-(2-hydroxy-4,6-dimethoxy-3
-isopentylphenyl-3-(4-methoxyphenyl)propane -(2-hydroxy-4,6-simethoxy3-isopentylphenyl)-3-(4-methoxyphenyl)-
0.17 g of aluminum chloride and 0.04 g of lithium aluminum hydride were carefully added to a solution of 0.20 g of 1-propanone in tetrahydrofuran (3 mZ) under water cooling, and the mixture was heated under reflux for 60 minutes. Subsequently, ethyl acetate and dilute hydrochloric acid were added to the reaction mixture, extracted with ether, washed with water, dried (anhydrous sodium sulfate), and then the solvent was distilled off. The residue was subjected to silica gel column chromatography (Merck 9385, φ=
25n+n+, H=220 mm, fraction 2~
5150 mf) to obtain 0.17 g (87%) of the title compound as a yellow oil.
分子式: Czs11izO4(372)黄色油状物
赤外線吸収スペクトルν□Xcm−’ (Neat)
:3580、2948.1614.1512.1246
.1150゜プロトン核磁気共鳴スペクトル(200M
Z)δppm。Molecular formula: Czs11izO4 (372) Yellow oil Infrared absorption spectrum ν□Xcm-' (Neat)
:3580, 2948.1614.1512.1246
.. 1150° proton nuclear magnetic resonance spectrum (200M
Z) δppm.
(CDCI:l) :
δ0.93(61Ld、J・6.6)、 61.32
〜1.40(2H。(CDCI:l): δ0.93 (61Ld, J・6.6), 61.32
~1.40 (2H.
mL 61.5〜1.65(LH,m) 、 61
.65〜1.79(211、m) 、 62.50〜
2.64 (611,m) 、 δ3.75(311
,5)、 63.77 (3H、S)、 δ3゜7
7 (3+1. S) 。mL 61.5-1.65 (LH, m), 61
.. 65~1.79 (211, m), 62.50~
2.64 (611, m), δ3.75 (311
,5), 63.77 (3H, S), δ3゜7
7 (3+1.S).
δ4.69(ill、S)、 66.09(LH,S
) 、 δ6.80(2H,dd、J=2.0.6.
611z)、 δ7.11 (2H,dd)マススペ
クトルm/z(χ)
372(M+、49)、 315(76)。δ4.69 (ill, S), 66.09 (LH, S
), δ6.80 (2H, dd, J=2.0.6.
611z), δ7.11 (2H, dd) Mass spectrum m/z (χ) 372 (M+, 49), 315 (76).
121 (2B)
(2)1−(4,6−シメトキシー2−メトキシカルボ
ニルメトキシ−3−イソペンチルフェニル)−3−(4
−メトキシフェニル)プロパン
(1)で得た化合物8.64gと水素化ナトリウム1.
25gの混合物に水冷下、窒素気流中で48mfのジメ
チルホルムアミドを注意しながら、ゆっくり滴下した。121 (2B) (2) 1-(4,6-Simethoxy2-methoxycarbonylmethoxy-3-isopentylphenyl)-3-(4
-methoxyphenyl)propane (1) and 1.64 g of the compound obtained with sodium hydride.
48 mf of dimethylformamide was carefully and slowly added dropwise to 25 g of the mixture under water cooling in a nitrogen stream.
水冷下で20分間撹拌したのらに、α−ブロム酢酸メチ
ル3.3 m/を滴下し、更に室温で10分間撹拌した
。反応終了後、反応混合物に水を加え、エーテル抽出し
たのち、水洗、乾燥(無水硫酸ナトリウム)し溶媒を留
去した。残留物をカラムクロマトグラフィー(シリカゲ
ル、Merck 9385、φ=70胴、H=330
mm、 650g、 Pr=0.4kgf/cm2、溶
離剤酢酸エチル−ヘキサン=2572)で分離し濃縮後
、ジエチルエーテル−ヘキサン系で結晶化したところ、
白色の固体として標記の化合物を7.09g(67%)
得た。After stirring for 20 minutes under water cooling, 3.3 m/ml of methyl α-bromoacetate was added dropwise, and the mixture was further stirred at room temperature for 10 minutes. After the reaction was completed, water was added to the reaction mixture, and the mixture was extracted with ether, washed with water, dried (anhydrous sodium sulfate), and the solvent was distilled off. The residue was subjected to column chromatography (silica gel, Merck 9385, φ=70 cylinder, H=330
mm, 650 g, Pr = 0.4 kgf/cm2, eluent ethyl acetate-hexane = 2572), and after concentration, crystallization with diethyl ether-hexane system.
7.09 g (67%) of the title compound as a white solid
Obtained.
分子式: Cz6]1:+aOa (444)融点:
53.5〜54.5°C
赤外線吸収スペクトルv mmXcm−’ KBr(D
isc)2944、1760.1608.1512.1
462.1242゜1156、1134
プロトン核磁気共鳴スペクトル(200MZ)δppm
。Molecular formula: Cz6]1:+aOa (444) Melting point:
53.5-54.5°C Infrared absorption spectrum v mmXcm-' KBr(D
isc) 2944, 1760.1608.1512.1
462.1242°1156, 1134 Proton nuclear magnetic resonance spectrum (200MZ) δppm
.
JH□、(CDC1ff) :
60.92(6H,d、J・6.6)、 61.22
〜1.42(2+1゜II+)、61.42〜1.65
(IH,n+)、 61.65〜1.84(28,m
)、 62.49〜2.65(68,m)、 δ3
.77゜3.79.3.80.3.81(12H,S)
、δ4.30(211,S)。JH□, (CDC1ff): 60.92 (6H, d, J・6.6), 61.22
~1.42 (2+1°II+), 61.42~1.65
(IH, n+), 61.65-1.84 (28, m
), 62.49-2.65 (68, m), δ3
.. 77゜3.79.3.80.3.81 (12H, S)
, δ4.30 (211, S).
δ6.28(111,S)、66.80(2H,dd、
J=2.帆6.6) 。δ6.28 (111, S), 66.80 (2H, dd,
J=2. Sail 6.6).
δ7.12(2H,dd)
マススペクトルm/z (X)
444(M”、too)、 387(82)、 309
(89)、 239(64)、 121(82)
(3)1−(2−カルボキシメトキシ−4,6−シメト
キシー3−イソペンチルフェニル)−3−(4−メトキ
シフェニル)プロパン
(2)で得た化合物7 、09gのメタノール(150
mf)溶液に5%水酸化カリウム45−を加え15分間
撹拌した。反応混合物に水冷下で希塩酸を加え、pH2
程度に調整したのちエーテル抽出し、水洗、乾燥(無水
硫酸ナトリウム)した。溶媒を留去したのちにジエチル
エーテル(少量)−石油エーテル−ヘキサン系で結晶化
したところ、白色の粉体として、標記の化合物を6.8
g(約100%)得た。δ7.12 (2H, dd) Mass spectrum m/z (X) 444 (M", too), 387 (82), 309
(89), 239(64), 121(82) (3) Obtained with 1-(2-carboxymethoxy-4,6-simethoxy-3-isopentylphenyl)-3-(4-methoxyphenyl)propane (2) Compound 7, 09 g of methanol (150
mf) 5% potassium hydroxide 45- was added to the solution and stirred for 15 minutes. Dilute hydrochloric acid was added to the reaction mixture under water cooling to adjust the pH to 2.
The mixture was extracted with ether, washed with water, and dried (anhydrous sodium sulfate). After distilling off the solvent, the title compound was crystallized from diethyl ether (a small amount)-petroleum ether-hexane system, and the title compound was obtained as a white powder with 6.8
g (approximately 100%) was obtained.
分子式: czsuz、o6(430)融点=69〜7
0.5°C
赤外線吸収スペクトルv mmxcm−’ KBr(D
isc)294B、 1740.1606.1510.
1462.1440゜1244、 1200. 115
0. 1128プロトン核磁気共鳴スペクトル(200
MZ)δppm。Molecular formula: czsuz, o6 (430) melting point = 69-7
0.5°C Infrared absorption spectrum v mmxcm-' KBr(D
isc) 294B, 1740.1606.1510.
1462.1440°1244, 1200. 115
0. 1128 proton nuclear magnetic resonance spectrum (200
MZ) δppm.
J 82. (CDC1+) :
60.92(6)1.d、J=6.4) 、 61.
36(21!、m)。J82. (CDC1+): 60.92 (6) 1. d, J=6.4), 61.
36 (21!, m).
61.59(IH,m)、 δ1.81(21LmL
62.47〜3.68 (68,m) 、δ3.7
? (3H,S) 、δ3.80 (3H、S) 。61.59 (IH, m), δ1.81 (21LmL
62.47~3.68 (68, m), δ3.7
? (3H,S), δ3.80 (3H,S).
δ3.81 (3H,S) 、δ4.34(2H,S)
、δ5.88(br。δ3.81 (3H,S), δ4.34 (2H,S)
, δ5.88 (br.
S)、66.30(IH,S) 、 δ6.81(2
11,dd、J・2.2゜6.6)、 δ7−12(
2H+dd、J=2.2+ 6.6)マススペクトルI
ll/z(χ)
430(M”、75)、 373(66)、 295(
95)、 225(74)、 12H100)
実施例4
■−(2−カルボキシメトキシ−4,6−シメトキシフ
エニル)−3−(4−メトキシフェニル)プロパン
(1)1−(2−ヒドロキシ−4,6−シメトキシフエ
ニル)−3−(4−メトキシフェニル)プロパン
U■
1−(2−ヒドロキシ−4,6−シメトキシフエニル)
−3−(4−メトキシフェニル)−1−プロパノン
(4,75g)のテトラヒドロフラン(THF) (1
5+n/) ?各法を、塩化アルミニウム(4,0g)
のT)IP(Ion/)懸濁液に加え、冷却した。更に
この反応混合液に水冷下で水素化アルミニウムリチウム
1.14gのTHF(15−)懸濁液を加え、超音波を
用いて、約2時間加熱還流した。反応終了後、反応混合
物に酢酸エチルと希塩酸を加えたのちにエーテル抽出し
、水洗、乾燥(無水硫酸ナトリウム)し、続いて溶媒を
留去した。残留物をシリカゲルカラムクロマトグラフィ
(Merck 9385 、φ70mm、 H=24
0 mm、シリカゲル470g、 Pr”’0.4kg
f/cm”、溶離剤酢酸エチル−ヘキサン=13)で分
離、精製したところ、油状物として標記化合物(74%
)得た。S), 66.30 (IH, S), δ6.81 (2
11, dd, J・2.2゜6.6), δ7-12(
2H+dd, J=2.2+ 6.6) Mass spectrum I
ll/z(χ) 430(M”, 75), 373(66), 295(
95), 225(74), 12H100) Example 4 ■-(2-carboxymethoxy-4,6-simethoxyphenyl)-3-(4-methoxyphenyl)propane (1) 1-(2-hydroxy- 4,6-Simethoxyphenyl)-3-(4-methoxyphenyl)propane U■ 1-(2-Hydroxy-4,6-Simethoxyphenyl)
-3-(4-methoxyphenyl)-1-propanone (4,75 g) in tetrahydrofuran (THF) (1
5+n/)? For each method, aluminum chloride (4.0 g)
T) IP (Ion/) suspension and cooled. Furthermore, a suspension of 1.14 g of lithium aluminum hydride in THF (15-) was added to this reaction mixture under water cooling, and the mixture was heated under reflux for about 2 hours using ultrasound. After the reaction was completed, ethyl acetate and dilute hydrochloric acid were added to the reaction mixture, which was then extracted with ether, washed with water, dried (anhydrous sodium sulfate), and then the solvent was distilled off. The residue was subjected to silica gel column chromatography (Merck 9385, φ70 mm, H=24
0 mm, silica gel 470g, Pr”'0.4kg
f/cm", eluent ethyl acetate-hexane = 13), the title compound (74%
)Obtained.
分子式: C1l+)+2□0. (302)油状物
赤外線吸収スペクトルν□Xcm−’ Neat :
3416、2936.1614.1598.1512.
1244゜プロトン核磁気共鳴スペクトル(200MZ
)δppm。Molecular formula: C1l+)+2□0. (302) Oily substance infrared absorption spectrum ν□Xcm-' Neat:
3416, 2936.1614.1598.1512.
1244° proton nuclear magnetic resonance spectrum (200MZ
) δppm.
JMZ:
61.74〜1.86(2H,m)、 62.59(
4H,t、 J・7.1)、 δ3.69(3)1.
S)、 δ3.74.3.75(S。JMZ: 61.74-1.86 (2H, m), 62.59 (
4H,t, J・7.1), δ3.69(3)1.
S), δ3.74.3.75 (S.
611)、δ5.55(LH,S)、65.99(LH
,d、J=2.2) 。611), δ5.55 (LH, S), 65.99 (LH
, d, J=2.2).
66.06(ill、d、J=2.4) 、 δ6.
80(2H,dd、 J・2.2.6.6Hz)、δ7
.H21+、dd、J=2.2.6.6!lz)。66.06 (ill, d, J=2.4), δ6.
80 (2H, dd, J・2.2.6.6Hz), δ7
.. H21+, dd, J=2.2.6.6! lz).
δ8.89(S)
マススペクトルm/z(χ)
148(24)、121(−Oll−@?−0CH3,
17)(2)l−(4,6−シメトキシー2−メトキシ
カルボニルメトキシフェニル)−3−(4−メトキシフ
ェニル)プロパン
上記(1)で得た化合物2.81gと水素化ナトリウム
0.23gの混合物に水冷下、N2気流中で10m1の
DMFを注意しながら、ゆっ(り滴下した。次に水冷下
で20分間撹拌したのちに、α−ブロム酢酸メチル1.
3 mfを滴下し、更に室温で10分間撹拌した。δ8.89 (S) Mass spectrum m/z (χ) 148 (24), 121 (-Oll-@?-0CH3,
17) (2) l-(4,6-Simethoxy2-methoxycarbonylmethoxyphenyl)-3-(4-methoxyphenyl)propane A mixture of 2.81 g of the compound obtained in (1) above and 0.23 g of sodium hydride. While cooling with water, 10 ml of DMF was slowly and carefully added dropwise in a N2 stream. Next, after stirring for 20 minutes under cooling with water, 1.
3 mf was added dropwise, and the mixture was further stirred at room temperature for 10 minutes.
反応終了後、反応混合物に水を加え、エーテル抽出した
のち、水洗、乾燥(無水硫酸ナトリウム)し溶媒を留去
した。残留物をカラムクロマトグラフィー(シリカゲル
Merck 9385、φ=70mm、 H=200+
+s、溶離剤Ac0Et−11ex= l : 5、P
r=0.4kgf/cn+”)で分離し、濃縮後、ジエ
チルエーテル−ヘキサン系で結晶化したところ、白色粉
末として標・配化合物を2.23g (64%)得た。After the reaction was completed, water was added to the reaction mixture, and the mixture was extracted with ether, washed with water, dried (anhydrous sodium sulfate), and the solvent was distilled off. The residue was subjected to column chromatography (silica gel Merck 9385, φ=70 mm, H=200+
+s, eluent Ac0Et-11ex=l : 5, P
r=0.4 kgf/cn+''), concentrated, and crystallized from diethyl ether-hexane system to obtain 2.23 g (64%) of the title compound as a white powder.
分子式: C!+Hzi06(374)融点:43〜4
4.5°C
赤外線吸収スペクトルv、、Xcra−’ KBr(D
isc) :2956、 1?62. 1612. 1
590. 1514. 1430゜1246、 121
8. 1200. 1188. 1174. 1156
プロトン核磁気共鳴スペクトル(200MZ)δppm
。Molecular formula: C! +Hzi06 (374) Melting point: 43-4
4.5°C Infrared absorption spectrum v,,Xcra-' KBr(D
isc) :2956, 1?62. 1612. 1
590. 1514. 1430°1246, 121
8. 1200. 1188. 1174. 1156
Proton nuclear magnetic resonance spectrum (200MZ) δppm
.
J N2. (CDCh) :
61.81(2H,m)、 62.56〜2.71
(4H,m) 。JN2. (CDCh): 61.81 (2H, m), 62.56-2.71
(4H, m).
δ3.74.3.75,3.76(1211,S)、
64 、58 ’(2II 。δ3.74.3.75, 3.76 (1211, S),
64, 58' (2II.
S)、65.98(IH,a、r=2.2)、 δ6
.19(LH,d。S), 65.98 (IH, a, r=2.2), δ6
.. 19 (LH, d.
J・2.2)、 66.80(2H,dd)、67.
11(2H,dd)マススペクトル−/z(Z) :
374(M”、100)、 239(100)、 14
8(27)。J・2.2), 66.80 (2H, dd), 67.
11 (2H, dd) mass spectrum -/z (Z): 374 (M”, 100), 239 (100), 14
8(27).
12H29)
(3)1−(2−カルボキシメトキシ−4,6−シメト
キシフエニル)−3−(4−メトキシフェニル)プロパ
ン
上記(2)で得た化合物0.5gのメタノール(5mり
溶液に5%水酸化カリウム2.5−を加え15分間撹拌
した。反応混合物に水冷下で希塩酸を加え、pH2程度
に調整したのちに析出した固体を濾取した。得られた標
記化合物は酢酸エチル(少量)−石油エーテル−ヘキサ
ン系で再結晶化され0.37g(80%)得た。12H29) (3) 1-(2-carboxymethoxy-4,6-simethoxyphenyl)-3-(4-methoxyphenyl)propane Add 0.5 g of the compound obtained in (2) above to methanol (5 mL solution). 2.5% of 5% potassium hydroxide was added and stirred for 15 minutes. Dilute hydrochloric acid was added to the reaction mixture under water cooling to adjust the pH to about 2, and the precipitated solid was collected by filtration. The title compound obtained was ethyl acetate ( 0.37 g (80%) was obtained by recrystallization from a petroleum ether-hexane system.
分子式二C2゜HznOi(360)
融点:103〜104.5℃
赤外線吸収スペクトルv、*xcm−’ KBr(Di
sc) :2932、1748.1606.1588.
1514.1428’。Molecular formula: 2C2゜HznOi (360) Melting point: 103-104.5℃ Infrared absorption spectrum v, *xcm-' KBr(Di
sc) :2932, 1748.1606.1588.
1514.1428'.
1256、1246.1168.1126プロトン核磁
気共鳴スペクトル(200MZ)δppm。1256, 1246.1168.1126 Proton nuclear magnetic resonance spectrum (200MZ) δppm.
JH□、(CDCIり :
61.78(2tl、m)、 62.59(2H,t
、J・8.9)。JH□, (CDCI: 61.78 (2tl, m), 62.59 (2H, t
, J.8.9).
δ2.65(2H,t、J・7.3)、 δ3.76
、3.7?。δ2.65 (2H, t, J・7.3), δ3.76
, 3.7? .
3.78(S、98)、 64.62(S、 ill
) 、 66.00(ill。3.78 (S, 98), 64.62 (S, ill
), 66.00 (ill.
d、J・2.2L δ6.17 (IH,d、 J=
2.2) 、 66.81(2H,dd、J・2.2.
6.6)、 67.11(2H,dd)マススペクト
ルn+/z(χ):
360(M”、18)、 302(10)、 225(
100)、 167(63)、 148(53)、 1
2H59)実施例5
l−(2−カルボキシメトキシ−4,6−シメトキシー
3−イソペンチルフェニル)−3−(4−メトキシフェ
ニル)−1−プロパノール(1)1−(2−ヒドロキシ
−4,6−シメトキシー3−イソペンチルフェニル)−
3−(4−メトキシフェニル)−1−プロパツール1−
(2−ヒドロキシ−4,6−ジメトキシ−3−イソペン
チルフェニル)−3−(4−メトキシフェニル)−1−
プロパノン10.0gのTIIP(lOOmf)溶液に
水冷下で水素化アルミニウムリチウム0.98gを加え
、室温に戻したのちに更に20分間撹拌した。反応混合
物に20rnlのTIIF−水(1: 1)と希塩酸を
加えたのちにエーテル抽出した。抽出物を水洗、乾燥(
無水硫酸ナトリウム)したのちに溶媒を留去したところ
粗結晶の標記化合物を9.1g (90%)得た。この
化合物の再結晶化はジエチルエーテル(少)−石油エー
テル−ヘキサン系で水冷下にて行なわれた。d, J・2.2L δ6.17 (IH, d, J=
2.2), 66.81 (2H, dd, J・2.2.
6.6), 67.11 (2H, dd) mass spectrum n+/z (χ): 360 (M”, 18), 302 (10), 225 (
100), 167(63), 148(53), 1
2H59) Example 5 l-(2-carboxymethoxy-4,6-simethoxy-3-isopentylphenyl)-3-(4-methoxyphenyl)-1-propanol (1) 1-(2-hydroxy-4,6 -Simethoxy3-isopentylphenyl)-
3-(4-methoxyphenyl)-1-propatool 1-
(2-hydroxy-4,6-dimethoxy-3-isopentylphenyl)-3-(4-methoxyphenyl)-1-
0.98 g of lithium aluminum hydride was added to a solution of 10.0 g of propanone in TIIP (lOOmf) under water cooling, and the mixture was returned to room temperature and stirred for an additional 20 minutes. After adding 20 rnl of TIIF-water (1:1) and dilute hydrochloric acid to the reaction mixture, the mixture was extracted with ether. Wash the extract with water and dry it (
After washing (anhydrous sodium sulfate), the solvent was distilled off to obtain 9.1 g (90%) of the title compound as crude crystals. Recrystallization of this compound was carried out in a diethyl ether (minor)-petroleum ether-hexane system under water cooling.
分子式:CBI13□o、(388)
融点: 76.5〜77°C
赤外線吸収スペクトルl’ m*xcm−’ (Nea
t) :3304、2948.1622.1600.
1512.1466゜1440、1384.1320.
1246.1214.1134゜1114、1086
プロトン核磁気共鳴スペクトル(200MZ)δppm
。Molecular formula: CBI13□o, (388) Melting point: 76.5-77°C Infrared absorption spectrum l'm*xcm-' (Nea
t) :3304, 2948.1622.1600.
1512.1466°1440, 1384.1320.
1246.1214.1134゜1114, 1086 Proton nuclear magnetic resonance spectrum (200MZ) δppm
.
J 82. (CDC13) :
60.94(611,d、J=6.4) 、 δ1.
37(2)1.m)。J82. (CDC13): 60.94 (611, d, J=6.4), δ1.
37(2)1. m).
δ1.58(LH,m)、 61.96〜2.18(
21Lm)。δ1.58 (LH, m), 61.96-2.18 (
21Lm).
62.46(ill、d、J・3.4)、 62.5
1〜2.77(411゜m)、63.73(3+1.S
) 、δ3.78(311,S) 、δ3.79(3H
,S)、 δ5.32(lfl、m)、 66.0
0(Ill、S)。62.46 (ill, d, J・3.4), 62.5
1 to 2.77 (411゜), 63.73 (3+1.S
), δ3.78(311,S), δ3.79(3H
,S), δ5.32(lfl,m), 66.0
0 (Ill, S).
66.8H2L’aa、J=2.2.6.6)、 6
7.12(21Ldd、J・2.2)、δ8.62(I
H,S)マススペクトルm/z(χ):
370(M”、388−H,0,34)、 313(3
2)、 179(50)、 121(100)
(2)1−(4,6−シメトキシー2−メトキシカルボ
ニルメトキシ−3−イソペンチルフェニル)−3−(4
−メトキシフェニル)−1−プロパツール
(1)で得た化合物1.20gと水素化ナトリウム0、
074gの混合物に氷冷下でDMF 10mjを加え1
5分間撹拌したのちに、α−ブロム酢酸メチル0.33
mfを加え更に5分間撹拌した。反応混合物に水を加え
、エーテル抽出、水洗、乾燥(無水硫酸ナトリウム)し
、溶媒を留去した。濃縮物をカラムクロマトグラフィー
(Merck 9385 、Pr=0.35kgf/c
ffl、シリカゲル150g、φ−50++un、 H
=180 nun、溶離剤酢酸エチル;ヘキサン=1:
3)で分離、精製したところ、標記化合物を油状物とし
て0.92g(64%)得た。66.8H2L'aa, J=2.2.6.6), 6
7.12 (21Ldd, J・2.2), δ8.62 (I
H, S) Mass spectrum m/z (χ): 370 (M", 388-H, 0, 34), 313 (3
2), 179(50), 121(100) (2) 1-(4,6-Simethoxy2-methoxycarbonylmethoxy-3-isopentylphenyl)-3-(4
-methoxyphenyl)-1-propatool (1) 1.20 g of the compound obtained and 0 sodium hydride,
Add 10mj of DMF to 074g of the mixture under ice cooling and add 1
After stirring for 5 minutes, methyl α-bromoacetate 0.33
mf was added and further stirred for 5 minutes. Water was added to the reaction mixture, extracted with ether, washed with water, dried (anhydrous sodium sulfate), and the solvent was distilled off. The concentrate was subjected to column chromatography (Merck 9385, Pr=0.35 kgf/c
ffl, 150g of silica gel, φ-50++un, H
=180 nun, eluent ethyl acetate; hexane = 1:
After separation and purification in step 3), 0.92 g (64%) of the title compound was obtained as an oil.
分子式: CzbH:+bOt(460)無色油状物
赤外線吸収スペクトルν□つcm−’ (Nea t)
:2948、1762.1604.1512.14
66、1246゜1206、1198.1124.10
90プロトン核磁気共鳴スペクトル(200MZ)δp
pm。Molecular formula: CzbH: +bOt (460) Colorless oil Infrared absorption spectrum ν□cm-' (Neat)
:2948, 1762.1604.1512.14
66, 1246°1206, 1198.1124.10
90 proton nuclear magnetic resonance spectrum (200MZ) δp
p.m.
J Hz、 (CDCl2) :
60.92(611,d、J・6.4)、 61.2
0〜1.44(2H。J Hz, (CDCl2): 60.92 (611, d, J・6.4), 61.2
0-1.44 (2H.
m)、61.55〜1.7(ill、m)、δ1.9〜
2.1 (ill。m), 61.55~1.7(ill, m), δ1.9~
2.1 (ill.
m)+62.18〜2.4(LH,m)、62.46〜
2.7(38゜m)+ 62.76〜2.9(LH,
m)、63.47(IH,d、J=11.2)、 6
3.77 (311、S) 、 63.81 (61(
、S) 。m) +62.18 ~ 2.4 (LH, m), 62.46 ~
2.7 (38゜) + 62.76~2.9 (LH,
m), 63.47 (IH, d, J = 11.2), 6
3.77 (311, S), 63.81 (61(
,S).
63、84 (311、S) 、 64.29(Il
l、d、J・15.6)。63, 84 (311, S), 64.29 (Il
l, d, J・15.6).
64.40(18,a、J=15.4)、64.9〜5
.1(ill。64.40 (18, a, J=15.4), 64.9~5
.. 1(ill.
m)、66.30(IH,S)、δ6.80(2)1.
dd、J=2.5゜6.6)、 δ7.11 (21
1,ad)マススペクトルm/z(χ):
442(M”、460−1t20.39)、 385(
39)、 353(22)、 19H42)、 145
(40)、 121(100)(3)1−(2−カルボ
キシメトキシ−4,6−ジメトキシ−3−イソペンチル
フェニル)−3−(4−メトキシフェニル)−1−プロ
パツール
(2)で得た化合物0.92gのメタノール(18mf
)溶液に5%水酸化カリウム水溶液(6d)を加え、1
0分間撹拌した。反応終了後、反応混合物に希塩酸を加
えpH2程度に調整したのちにエーテル抽出、水洗、乾
燥(無水硫酸ナトリウム)した。溶媒留去後、濃縮物を
ジエチルエーテル−ヘキサン系で結晶化したところ、白
色粉体として、0.45g(50%)の標記化合物を得
た。m), 66.30 (IH, S), δ6.80 (2) 1.
dd, J=2.5゜6.6), δ7.11 (21
1, ad) Mass spectrum m/z (χ): 442 (M", 460-1t20.39), 385 (
39), 353(22), 19H42), 145
(40), 121(100)(3) obtained with 1-(2-carboxymethoxy-4,6-dimethoxy-3-isopentylphenyl)-3-(4-methoxyphenyl)-1-propanol (2) 0.92 g of methanol (18 mf
) Add 5% potassium hydroxide aqueous solution (6d) to the solution,
Stirred for 0 minutes. After the reaction was completed, dilute hydrochloric acid was added to the reaction mixture to adjust the pH to about 2, followed by extraction with ether, washing with water, and drying (anhydrous sodium sulfate). After evaporating the solvent, the concentrate was crystallized using diethyl ether-hexane system to obtain 0.45 g (50%) of the title compound as a white powder.
分子式: czst+5407(446)融点二69〜
70.5°C
赤外線吸収スペクトルν、、Xcm−’ KBr(Di
sc) :3536、2952.1754.1606.
1586.1514゜1466、1454.1440.
1324.1246.1200゜プロトン核磁気共鳴ス
ペクトル(200MZ)δppm。Molecular formula: czst+5407 (446) Melting point 269~
70.5°C Infrared absorption spectrum ν,,Xcm-' KBr(Di
sc) :3536, 2952.1754.1606.
1586.1514°1466, 1454.1440.
1324.1246.1200° proton nuclear magnetic resonance spectrum (200MZ) δppm.
J□z、(CDCh) :
61.35〜1.43(2H,m)、 61.55〜
1.62(01゜m)、 δ1.97〜2.Hlll
、m)、δ2.1 〜2.40(lll、m)、 δ
2.4 〜2.62(311,m)、 62.71〜
2.9(LH,m)、、63.76(311,S) 、
δ3.81,3.82(6H,S)、 δ4.3
4 (III、 d、 ・15.6)、δ4.48(
ill、d、 J=15.6)、 65.13(L
H,dd、 J・8.6゜5.3)、 66.28
(Ill、 S) 、 66.78(2H,dd、
J・2.2. 6.6)、 67.08(211,
dd)マススペクトルm/z(り :
428(M”、446−11□O)、 37H41)、
237(13)。J□z, (CDCh): 61.35~1.43 (2H, m), 61.55~
1.62 (01゜m), δ1.97~2. Hllll
, m), δ2.1 ~ 2.40 (lll, m), δ
2.4 ~ 2.62 (311, m), 62.71 ~
2.9 (LH, m), , 63.76 (311, S),
δ3.81, 3.82 (6H, S), δ4.3
4 (III, d, ・15.6), δ4.48 (
ill, d, J=15.6), 65.13(L
H, dd, J・8.6°5.3), 66.28
(Ill, S), 66.78 (2H, dd,
J・2.2. 6.6), 67.08 (211,
dd) Mass spectrum m/z (ri: 428 (M”, 446-11□O), 37H41),
237(13).
19H42)、 121(100)
実施例6
l−(2−ヒドロキシエトキシ−4,6−シメトキシー
3−イソペンチルフェニル)−3−(4−メトキシフェ
ニル)−1−プロパツール実施例3(2)で得た1−(
4,6−シメトキシー2−メトキシカルボニルメトキシ
−3−イソペンチルフェニル)−3−(4−メトキシフ
ェニル)−1−プロパノン5.2gと水素化アルミニウ
ムリチウム0.51gの混合物に冷却下でジエチルエー
テル84m1を加え、室温に戻したのちに更に60分間
加熱還流した。反応終了後、反応混合物に酢酸エチルと
希塩酸を加えたのちエーテル抽出した。抽出液を水洗、
乾燥(無水硫酸ナトリウム)し、溶媒を留去し、たのち
に酢酸エチル(少量)−ジエチルエーテル−ヘキサン系
で結晶化したところ、白色の針状晶として標記化合物を
4. L2g (87%)得た。19H42), 121(100) Example 6 l-(2-hydroxyethoxy-4,6-simethoxy-3-isopentylphenyl)-3-(4-methoxyphenyl)-1-propatol Example 3(2) Obtained 1-(
84 ml of diethyl ether was added to a mixture of 5.2 g of 4,6-simethoxy-2-methoxycarbonylmethoxy-3-isopentylphenyl)-3-(4-methoxyphenyl)-1-propanone and 0.51 g of lithium aluminum hydride under cooling. was added, the temperature was returned to room temperature, and the mixture was further heated under reflux for 60 minutes. After the reaction was completed, ethyl acetate and dilute hydrochloric acid were added to the reaction mixture, followed by extraction with ether. Wash the extract with water,
After drying (anhydrous sodium sulfate) and distilling off the solvent, crystallization from ethyl acetate (a small amount)-diethyl ether-hexane system yielded the title compound as white needle-like crystals. 2g (87%) of L was obtained.
分子式: Cz、HxbObC432>融点: 99.
5〜100°C
赤外線吸収スペクトルv 11.xcm−’ KBr(
Disc) :3548、3376、2948.160
4.1590.1514゜1454、1246.119
6.1126.1088.10?4゜1038、100
4
プロトン核磁気共鳴スペクトル(200)IZ)δpp
m。Molecular formula: Cz, HxbObC432>Melting point: 99.
5-100°C Infrared absorption spectrum v 11. xcm-' KBr(
Disc): 3548, 3376, 2948.160
4.1590.1514゜1454, 1246.119
6.1126.1088.10?4゜1038, 100
4 Proton nuclear magnetic resonance spectrum (200) IZ) δpp
m.
J H2,(CDC13) :
60.93(6B、d、J=6.4)、 61.31
〜1.42(2+1゜m)+ δ1.48〜1.70
(IH,m)、 61.90〜2.10(III、m
)、 62.26〜2.42(Ill、m)、 δ
2.44〜2.82(5H,m) 、 δ3.76〜
3.85 (138) 、δ4.93(III、m)、
66.29(IH,S)、 δ6.89(28,
dd、J=2.2. 6.6)、 67.13(2H
,dd、J・2.2. 6.6)マススペクトルm/z
(χ):
414(M”、432−H2O,14)、 279(1
00)、 121実施例7
l−(2−ヒドロキシエトキシ−4,6−シメトキシフ
エニル)−3−(4−メトキシフェニル)−1−プロパ
ツール
(1)1=(2−ヒドロキシ−4,6−シメトキシフエ
ニル)−3−(4−メトキシフェニル)−1−プロパノ
ール
水素化アルミニウムリチウム1.01gのジエチルエー
テル(15mり懸ン蜀ン夜に1−(2−ヒドロキシ−4
,6−シメトキシフエニル)−3−(4−メトキシフェ
ニル)−1−プロパノン8.0gのTHF(30m)溶
液を加え60分間撹拌した。反応終了後、反応混合物に
酢酸エチルと希塩酸を加えエーテル抽出し、水洗、乾燥
(無水硫酸ナトリウム)したのちに溶媒を留去したとこ
ろ標記化合物を白色粉末として7.32 g (89%
)得た。J H2, (CDC13): 60.93 (6B, d, J=6.4), 61.31
~1.42 (2+1゜m) + δ1.48~1.70
(IH, m), 61.90-2.10 (III, m
), 62.26-2.42 (Ill, m), δ
2.44~2.82 (5H, m), δ3.76~
3.85 (138), δ4.93 (III, m),
66.29 (IH, S), δ6.89 (28,
dd, J=2.2. 6.6), 67.13 (2H
, dd, J.2.2. 6.6) Mass spectrum m/z
(χ): 414 (M”, 432-H2O, 14), 279 (1
00), 121 Example 7 l-(2-hydroxyethoxy-4,6-simethoxyphenyl)-3-(4-methoxyphenyl)-1-propatol (1) 1=(2-hydroxy-4, 6-Simethoxyphenyl)-3-(4-methoxyphenyl)-1-propanol Lithium aluminum hydride 1.01 g of diethyl ether (15 m
,6-Simethoxyphenyl)-3-(4-methoxyphenyl)-1-propanone (8.0 g) in THF (30 m) was added and stirred for 60 minutes. After the reaction was completed, ethyl acetate and dilute hydrochloric acid were added to the reaction mixture, extracted with ether, washed with water, dried (anhydrous sodium sulfate), and the solvent was distilled off to give 7.32 g (89%) of the title compound as a white powder.
)Obtained.
分子式: Czs)lzzOs(438)融点: 75
.5〜76.5°C
赤外線吸収スペクトルv +s@Xcm−’ KBr(
Dtsc) :3464、1628.159B、 12
42.1210.1196゜1150、1098.10
48
プロトン核磁気共鳴スペクトル(200MZ)δppm
。Molecular formula: Czs)lzzOs (438) Melting point: 75
.. 5 to 76.5°C Infrared absorption spectrum v +s@Xcm-' KBr(
Dtsc) :3464, 1628.159B, 12
42.1210.1196°1150, 1098.10
48 Proton nuclear magnetic resonance spectrum (200MZ) δppm
.
J工z、(CDC1z) :
δ1.92〜2.22(2H,m)、 δ2.70(
d、J=3.9)。J engineering z, (CDC1z): δ1.92-2.22 (2H, m), δ2.70 (
d, J=3.9).
62.54〜2.83(3H,m)、 δ3.69(
3H,S) 。62.54-2.83 (3H, m), δ3.69 (
3H,S).
63.74 (311、S) 、 δ3.7?(3+
1.S)、 65.27(ltl、m)、 δ5.
97(IH,d、J、2.2)、 66.05(il
l、d、J・2.2)、66.81 (2H,dd、
J・2.2.6.6)。63.74 (311, S), δ3.7? (3+
1. S), 65.27 (ltl, m), δ5.
97 (IH, d, J, 2.2), 66.05 (il
l, d, J・2.2), 66.81 (2H, dd,
J.2.2.6.6).
δ7.IH21+、dd、J、2.0)、68.74(
11(、S)マススペクトルm/z(X) :
300(M”、318−tfzO,67)、 283(
18)、 191(25)、 166(33)、 14
7(51)、 134(85)、 121(2)1−(
4,6−シメトキシー2−メトキシカルボニルメトキシ
フェニル)−3−(4−メトキシフェニル)−1−プロ
パツール
上記(1)で得た化合物5.37gと水素化ナトリウム
0.41gの混合物に冷却下でDMF 100m1を加
え、20分間撹拌したのちにα−ブロム酢酸メチル2.
14m1を加え更に10分間撹拌した。反応混合物に水
を加え、エーテル抽出、水洗、乾燥(無水硫酸ナトリウ
ム)し、溶液を留去したところ無色透明の油状物として
標記化合物をほぼ定量的に得た。δ7. IH21+, dd, J, 2.0), 68.74 (
11(,S) Mass spectrum m/z(X): 300(M”, 318-tfzO,67), 283(
18), 191(25), 166(33), 14
7(51), 134(85), 121(2)1-(
4,6-Simethoxy2-methoxycarbonylmethoxyphenyl)-3-(4-methoxyphenyl)-1-propatol was added to a mixture of 5.37 g of the compound obtained in (1) above and 0.41 g of sodium hydride under cooling. After adding 100 ml of DMF and stirring for 20 minutes, methyl α-bromoacetate 2.
14 ml was added and stirred for an additional 10 minutes. Water was added to the reaction mixture, and the mixture was extracted with ether, washed with water, dried (anhydrous sodium sulfate), and the solution was distilled off to give the title compound as a colorless and transparent oil almost quantitatively.
分子式: Cz+L6(h(390)
無色油状物
赤外線吸収スペクトルν。axcIl+−’ Neat
:3544、2952.1?58.1614.15
94.1512゜1454、1438.1246.12
16.1198.1156゜1130、1060.10
36
プロトン核磁気共鳴スペクトル(200MZ)δpp+
m。Molecular formula: Cz+L6(h(390) Colorless oil infrared absorption spectrum ν.axcIl+-' Neat
:3544, 2952.1?58.1614.15
94.1512°1454, 1438.1246.12
16.1198.1156°1130, 1060.10
36 Proton nuclear magnetic resonance spectrum (200MZ) δpp+
m.
J Hz、(CDC1i) ’
δ1.97〜2.3(28,m)、52.46〜2.8
(2H,m)。J Hz, (CDC1i)' δ1.97-2.3 (28, m), 52.46-2.8
(2H, m).
δ3.75.3.76、3.78.3.79(12H,
s)、 δ3.87 (IH,d、 J・11.72
)、 64.61(2H,S)、65.08〜5.2
1 (LH,m) 、66.00(1B、d、J=2.
2) 。δ3.75.3.76, 3.78.3.79 (12H,
s), δ3.87 (IH, d, J・11.72
), 64.61 (2H, S), 65.08-5.2
1 (LH, m), 66.00 (1B, d, J=2.
2).
66.15(IH,d、J・2.0)、66.79(2
H,dd、J・2.2゜6.6)、 67.12(2
11,dd、J=2.2.6.6)マススペクトルm/
z(χ):
372(M”、390−H2O,82)、 299(7
2)、 283(35)、145(75)、121(1
00)(3)1−(2−ヒドロキシエトキシ−4,6−
シメトキシフエニル)−3−(4−メトキシフェニル)
−1−プロパツール
(2)で得た化合物0.22gのジエチルエーテル(4
/)溶液に水冷下で水素化アルミニウムリチウム0.0
5gを加え、室温で戻したのちに超音波を用いて2時間
還流した。反応終了後、反応混合物に酢酸エチルと希塩
酸を加え、エーテル抽出した。66.15 (IH, d, J・2.0), 66.79 (2
H, dd, J・2.2゜6.6), 67.12 (2
11, dd, J=2.2.6.6) Mass spectrum m/
z (χ): 372 (M”, 390-H2O, 82), 299 (7
2), 283 (35), 145 (75), 121 (1
00)(3)1-(2-hydroxyethoxy-4,6-
cymethoxyphenyl)-3-(4-methoxyphenyl)
-1-Propatool (2) Compound 0.22g diethyl ether (4
/) Lithium aluminum hydride 0.0 in solution under water cooling
After adding 5 g of the mixture and returning it to room temperature, the mixture was refluxed for 2 hours using ultrasound. After the reaction was completed, ethyl acetate and dilute hydrochloric acid were added to the reaction mixture, and the mixture was extracted with ether.
抽出液を水洗、乾燥(無水硫酸ナトリウム)と溶媒を留
去したのちにカラムクロマトグラフィー(Merck
9385 、シリカゲル35g、φ=20mm、 H=
150 mm、 Pr=0.35kgf/cJ)で分離
精製し、無色透明の油状物として標記化合物を0.2g
(定量的)得た。The extract was washed with water, dried (anhydrous sodium sulfate), and the solvent was distilled off, followed by column chromatography (Merck
9385, 35g of silica gel, φ=20mm, H=
150 mm, Pr = 0.35 kgf/cJ) to obtain 0.2 g of the title compound as a colorless and transparent oil.
(Quantitative) Obtained.
実施例8
4、4’、 6’−トリエトキシ−3′−イソベンチル
ー2′−カルポキシメトキシカルコン
(1)4’、6′〜ジェトキシ−2′−ヒドロキシ−3
′−(3−メチル−2−ブテニル)アセトフェノン
2’、4’、6’−)リヒドロキシ−3’−(3−メチ
ル−2−ブテニル)アセトフェノン2.0gと炭酸カリ
ウム3.0gとのアセトン(10mZ)懸濁溶液に、ジ
エチル硫酸2.4.dを加え20時間撹拌した。反応終
了後、固体を除去し、濾液を濃縮した。析出した固体を
冷メタノールで数回洗浄したところ、標記化合物を白色
の粉体として、1.51g(61%)得た。Example 8 4,4',6'-triethoxy-3'-isobenthyl-2'-carpoxymethoxychalcone (1) 4',6'-jethoxy-2'-hydroxy-3
'-(3-Methyl-2-butenyl)acetophenone 2',4',6'-)lihydroxy-3'-(3-methyl-2-butenyl)acetophenone 2.0g and potassium carbonate 3.0g in acetone (10 mZ) into the suspension solution, add 2.4. d was added and stirred for 20 hours. After the reaction was completed, the solids were removed and the filtrate was concentrated. The precipitated solid was washed several times with cold methanol to obtain 1.51 g (61%) of the title compound as a white powder.
分子式: C+JgiOn(292)
融点: 98.4〜98.2°C
赤外線吸収スペクトルν□xcm−’(KBr) :
29B4.1624.1592.1430.1272.
1234゜1172、1120.870
プロトン核磁気共鳴スペクトル(200Mllz)δC
DCl+ ′(ppn+、 J=Hz) :
1.44(3H,t、J=7.0)、 1.48(3
H,t、J・6.8)。Molecular formula: C+JgiOn (292) Melting point: 98.4-98.2°C Infrared absorption spectrum ν□xcm-' (KBr):
29B4.1624.1592.1430.1272.
1234°1172, 1120.870 Proton nuclear magnetic resonance spectrum (200 Mllz) δC
DCl+' (ppn+, J=Hz): 1.44 (3H, t, J=7.0), 1.48 (3
H, t, J・6.8).
1.66(311,s)、 1.77(3tl、s)
、 2.63(3H,s)。1.66 (311, s), 1.77 (3tl, s)
, 2.63 (3H, s).
3.27(2H,d、J=7.3)、 4.07(4
11,q、J・6.8)。3.27 (2H, d, J = 7.3), 4.07 (4
11, q, J・6.8).
5.21(18,m、J=1.5. 7.3)、 5
.87(LH,s)。5.21 (18, m, J=1.5.7.3), 5
.. 87 (LH, s).
13.94<s)
マススペクトルm/z (χ) [EI−MS] :2
92(M″、 78)、 263(too)、
237(64)、 221(2)4’、6’−ジェト
キシ−2−ヒドロキシ−3′−イソペンチルアセトフェ
ノン
予め水素を吸着させたPd−C(5%)0.3gの酢酸
エチル100/懸濁液に(1)で得た化合物の酢酸エチ
ル溶液を加え、更に水素を吸着させた0反応終了後、セ
ライトを用いてPd−Cを除き、減圧下で溶液を留去し
た。残留物にヘキサンを加え結晶化したところ標記化合
物を、白色の針状晶として1゜60g (79%)得た
。13.94<s) Mass spectrum m/z (χ) [EI-MS] :2
92 (M″, 78), 263 (too),
237(64), 221(2) 4',6'-Jethoxy-2-hydroxy-3'-isopentylacetophenone 0.3 g of Pd-C (5%) preadsorbed with hydrogen in ethyl acetate 100/suspension An ethyl acetate solution of the compound obtained in (1) was added to the solution, and after the completion of the reaction in which hydrogen was adsorbed, Pd-C was removed using Celite, and the solution was distilled off under reduced pressure. Hexane was added to the residue to crystallize it, yielding 1.60 g (79%) of the title compound as white needle-like crystals.
分子式: C1?lft、04 (294)融点:10
5.1〜105.5℃
赤外線吸収スペクトルν、、、cm−’(KBr)
:2956、1632.1592.1426.1272
.1142゜1078 ′
プロトン核磁気共鳴スペクトル(200Ml(z)δC
DCI x(pp蒙、 J=Hz) :
0.93(d、J・6.4)、 1.40(t、J・6
.8)+ 1.43(t、J=6.8)、 1.28〜
1.61(n+)、 2.63(s)。Molecular formula: C1? lft, 04 (294) Melting point: 10
5.1~105.5℃ Infrared absorption spectrum ν,, cm-' (KBr)
:2956, 1632.1592.1426.1272
.. 1142°1078' Proton nuclear magnetic resonance spectrum (200Ml(z)δC
DCI x (ppmong, J=Hz): 0.93 (d, J・6.4), 1.40 (t, J・6
.. 8) + 1.43 (t, J=6.8), 1.28~
1.61 (n+), 2.63 (s).
2.56(t)、 4.05(q、J・6.8)、 4
.07(q、J・6.8)。2.56 (t), 4.05 (q, J・6.8), 4
.. 07 (q, J・6.8).
5.89 (s)
マススペクトルm/z(X) [EI −MS] :
294(M’、56)、 237(100)、 209
(47)(3) 4.4’、 6’−)ジェトキシ−2
′−ヒドロキシ−3−イソペンチルカルコン
(2)で得た化合物11.54gとp−エトキシベンズ
アルデヒド6、15gのエタノール−ジメチルスルホキ
シド混合(100af)溶液に、撹拌しながら、飽和水
酸化カリウム−エタノール溶液120m1を加え室温で
20時間撹拌した0反応終了後、反応混合物に希塩酸を
加え弱酸性にしたのち析出した固体を濾取した。析出物
を酢酸エチルで溶解したのち、水洗、乾燥し続いて溶媒
を留去した。濃縮物を酢酸エチル−メタノール系で結晶
化したところ、赤橙色の結晶として標記化合物を14.
95g(90%)得た。5.89 (s) Mass spectrum m/z (X) [EI-MS]:
294 (M', 56), 237 (100), 209
(47) (3) 4.4', 6'-) Jetoxy-2
A saturated potassium hydroxide-ethanol solution was added to a solution of 11.54 g of the compound obtained from '-hydroxy-3-isopentylchalcone (2) and 6.15 g of p-ethoxybenzaldehyde in ethanol-dimethyl sulfoxide mixture (100 af) with stirring. 120 ml was added and stirred at room temperature for 20 hours. After completion of the reaction, dilute hydrochloric acid was added to the reaction mixture to make it slightly acidic, and the precipitated solid was collected by filtration. The precipitate was dissolved in ethyl acetate, washed with water, dried, and then the solvent was distilled off. When the concentrate was crystallized from an ethyl acetate-methanol system, the title compound was obtained as red-orange crystals in 14.
95g (90%) was obtained.
分子式: CzJi40s(426)
融点: 126.3〜126.7°C
赤外線吸収スペクトル!l m*xcm−’ (KBr
) :2980、2952.1622.1576、1
554.1512゜1424、1288.1256.1
230.1216.1160゜プロトン核磁気共鳴スペ
クトル(200Ml(z)δCDCDC13(pp J
(llz) :
0.94(6H,d、J・6.4)、 1.34〜1.
60(12H,m)。Molecular formula: CzJi40s (426) Melting point: 126.3-126.7°C Infrared absorption spectrum! l m*xcm-' (KBr
) :2980, 2952.1622.1576, 1
554.1512°1424, 1288.1256.1
230.1216.1160°Proton nuclear magnetic resonance spectrum (200Ml(z)δCDCDC13(pp J
(llz): 0.94 (6H, d, J・6.4), 1.34-1.
60 (12H, m).
2.59(2H,m)、 4.01〜4.15(611
,m)、 5.93(18,s)、 6.89(211
,dd、J=2.0.6.84)、 7.52(28,
dd、J=2.0.6.8)、 7.72(IH,d、
15.6)。2.59 (2H, m), 4.01-4.15 (611
, m), 5.93 (18, s), 6.89 (211
, dd, J=2.0.6.84), 7.52 (28,
dd, J=2.0.6.8), 7.72(IH, d,
15.6).
7.90(ltl、d、15.6) マススペクトルm/z (χ)[EI−MS] 。7.90 (ltl, d, 15.6) Mass spectrum m/z (χ) [EI-MS].
426(M”、 66)、 369(39)、 221
(100)、 165(4B)、 135(33)
(4)4.4’、6’−トリエトキシ−2′−メトキシ
カルボニルメトキシ−3′−イソペンチルカルコン
(3)で得た化合物1.0g、無水炭酸カリウム0.5
2gとヨウ化カリウム0.1gのDMF(10m/)溶
液を窒素雰囲気下、室温で45分間撹拌した。続いて反
応混合物に、ブロム酢酸メチル0.27m/を滴下し、
更に12時間撹拌した。反応終了後、反応混合物に水を
加え酢酸エチルで抽出した。抽出溶液を水洗、乾燥(無
水硫酸ナトリウム)したのちに溶媒を留去L、酢酸エチ
ル−ジエチルエーテル−ヘキサン系で結晶化したところ
、淡黄色の固体として標記化合物を0.91g(79%
)得た。426 (M”, 66), 369 (39), 221
(100), 165(4B), 135(33) (4) 1.0 g of the compound obtained from 4.4',6'-triethoxy-2'-methoxycarbonylmethoxy-3'-isopentylchalcone (3), Anhydrous potassium carbonate 0.5
A solution of 2 g of potassium iodide and 0.1 g of potassium iodide in DMF (10 m/) was stirred at room temperature for 45 minutes under a nitrogen atmosphere. Subsequently, 0.27 m/m of methyl bromoacetate was added dropwise to the reaction mixture.
The mixture was further stirred for 12 hours. After the reaction was completed, water was added to the reaction mixture and extracted with ethyl acetate. After washing the extracted solution with water and drying (anhydrous sodium sulfate), the solvent was distilled off and crystallized with ethyl acetate-diethyl ether-hexane system, yielding 0.91 g (79%) of the title compound as a pale yellow solid.
)Obtained.
分子式: CzJ:+5Qt(49B)融点: 84.
2℃
赤外線吸収スペクトルy saxCm−’ (KBr)
:2952、1748.1662.1600.15
74.1224゜プロトン核磁気共鳴スペクトル(20
0111z)δCDC1z(ppm、 J=Hz)
:
0.94(61(、d、J・6.3)、 1.28(3
H,t、J=7.0)。Molecular formula: CzJ:+5Qt(49B) Melting point: 84.
2℃ Infrared absorption spectrum ysaxCm-' (KBr)
:2952, 1748.1662.1600.15
74.1224° proton nuclear magnetic resonance spectrum (20
0111z) δCDC1z (ppm, J=Hz)
: 0.94(61(,d,J・6.3), 1.28(3
H, t, J = 7.0).
1.38〜1.48(8)1.m)、 1.58〜1.
67(IH,m)。1.38-1.48(8)1. m), 1.58-1.
67 (IH, m).
2.60(2H,m)、 3.73(3H,s)、 3
.94〜4.11(6H+m)+ 4.50(2)1.
s)、 6.29(IH,s)、 6.87(2H,d
d、J・1.9. 6.8)、 6.88(IH,d
、J=16.0)。2.60 (2H, m), 3.73 (3H, s), 3
.. 94~4.11(6H+m)+4.50(2)1.
s), 6.29 (IH, s), 6.87 (2H, d
d, J・1.9. 6.8), 6.88(IH, d
, J=16.0).
7.31 (111,d、 J・16.0)、 7.
45(2Ldd、J・1.9゜6.8)
マススペクトルm/z(χ) [EI−MS] :49
8(M”、 55)、 441(83)、 439(8
6)、 369(39)、 265(61)、 175
(55)、 135(100)(5)2’−カルボキシ
メトキシ−4,4’、6−ドリエトキシー3−イソペン
チルカルコン(4)で得た化合物4.1gのメタノール
(100ml)溶液に5%−KOH(aq) 50−を
加え、室温で20分間撹拌した。反応終了後、反応混合
物に希塩酸を加え弱酸性とした後に多量の水□を加えた
。析苗した固体を濾取した後く酢酸エチル−ヘキサン系
で結晶化したところ淡黄色の固体として標記化合物を3
.02g(76%)得た。7.31 (111, d, J・16.0), 7.
45 (2Ldd, J・1.9°6.8) Mass spectrum m/z (χ) [EI-MS]: 49
8 (M”, 55), 441 (83), 439 (8
6), 369(39), 265(61), 175
(55), 135(100)(5) A solution of 4.1 g of the compound obtained from 2'-carboxymethoxy-4,4',6-driethoxy-3-isopentylchalcone (4) in methanol (100 ml) at 5% KOH(aq) 50- was added and stirred at room temperature for 20 minutes. After the reaction was completed, dilute hydrochloric acid was added to the reaction mixture to make it weakly acidic, and then a large amount of water was added. The separated solid was collected by filtration and then crystallized with ethyl acetate-hexane system to yield the title compound as a pale yellow solid.
.. 02g (76%) was obtained.
分子式: Cz*HzbOt(484)融点7130.
3〜130.9°C
赤外線吸収スペクトルシ、□cm−’ (K3r)
:2956、1736.1644.1602.1574
.1510.“1276、1250.1166、113
8.1116.1100プロトン核磁気共鳴スペクトル
(200MHz)δCDCl5(pp+w、 J=Hz
) :
0.99(6H,d、J=6.3)、 1.24(3H
,t、J・7.1)。Molecular formula: Cz*HzbOt (484) Melting point 7130.
3-130.9°C Infrared absorption spectrum, □cm-' (K3r)
:2956, 1736.1644.1602.1574
.. 1510. “1276, 1250.1166, 113
8.1116.1100 Proton nuclear magnetic resonance spectrum (200MHz) δCDCl5 (pp+w, J=Hz
): 0.99 (6H, d, J=6.3), 1.24 (3H
, t, J・7.1).
1.38(t、J・7.1)、 1.43(t、J・6
.8)、 1.49〜1.64(ltl、m)、 2.
64(211,m)、 4.09(q、J=7.1)。1.38 (t, J・7.1), 1.43 (t, J・6
.. 8), 1.49-1.64 (ltl, m), 2.
64 (211, m), 4.09 (q, J=7.1).
4.14(q、J=6.8)、 4.48(2H,s)
、 6.54(III、s)。4.14 (q, J=6.8), 4.48 (2H, s)
, 6.54 (III, s).
6.93(IH,d、J=16.0)、 6.95(2
1Ldd、J=2.帆6.8)、 7.34(IH,d
、、L、16.0)、 7.59(2B、dd。6.93 (IH, d, J = 16.0), 6.95 (2
1Ldd, J=2. Sail 6.8), 7.34 (IH, d
,, L, 16.0), 7.59 (2B, dd.
2.0.6.8)
マススペクトル…/z(χ)−[EI−MSI :
。2.0.6.8) Mass spectrum.../z(χ)-[EI-MSI:
.
484(M”、 76)、 439(48)、 427
(67)、 369(36)、 25H52)、 22
1(58)、 135(100)元素分析:
計算値、 C: 69゜48 H: 7.41実測値
、 C: 69.40 H: 7.48実施例9
2′−カルボキシメトキシ−4’、6′−ジェトキシ−
4−メトキシ−3′−イソベンチルカルコン(1)4’
、6’−ジェトキシ−2′−ヒドロキシ−4−メトキシ
−3′−イソペンチルカルコン実施例8(2)で得た4
’、6′−ジェトキシ−2′−ヒドロキシ−3′−イソ
ペンチルアセトフェノン9、17gとp−メトキシベン
ズアルデヒド4.60gのエタノール−ジメチルスルホ
キシド混合(100ml)溶液に、撹拌しながら、飽和
水酸化カリウム−エタノール溶液100 mlを加え室
温で20時間撹拌した。484 (M”, 76), 439 (48), 427
(67), 369(36), 25H52), 22
1 (58), 135 (100) Elemental analysis: Calculated value, C: 69°48 H: 7.41 Actual value, C: 69.40 H: 7.48 Example 9 2'-carboxymethoxy-4', 6'-jetoxy-
4-Methoxy-3'-isobentylchalcone (1) 4'
, 6'-jethoxy-2'-hydroxy-4-methoxy-3'-isopentyl chalcone 4 obtained in Example 8 (2)
',6'-Jethoxy-2'-hydroxy-3'-isopentylacetophenone 9.17 g and p-methoxybenzaldehyde 4.60 g were added to a solution of ethanol-dimethyl sulfoxide mixture (100 ml) while stirring. 100 ml of ethanol solution was added and stirred at room temperature for 20 hours.
反応終了後、反応混合物に希塩酸を加え弱酸性にしたの
ち析出した固体を濾取した。沈澱物を酢酸エチルモ溶解
したのち、水洗、乾燥し続いて溶媒を留去した。濃縮物
を酢酸エチル−石油エーテル系で結晶化したところ、赤
橙色の結晶として標記化合物を10.97g(86%)
得た。After the reaction was completed, dilute hydrochloric acid was added to the reaction mixture to make it slightly acidic, and the precipitated solid was collected by filtration. The precipitate was dissolved in ethyl acetate, washed with water, dried, and then the solvent was distilled off. When the concentrate was crystallized with ethyl acetate-petroleum ether system, 10.97 g (86%) of the title compound was obtained as red-orange crystals.
Obtained.
分子式: CzsTo□O,(412)融点: 122
.0〜122.4°C
赤外線吸収スペクトルv 、、、cm−’ (KBr)
:2960、1626.1606.1558.12
52.1232゜1218、1172.1160.11
34.826プロトン核磁気共鳴スペクトル(200M
Hz)δCDCI !(ppm、 J=)Iz) :
0.94(6H,d、J・6.4)、 1.31〜1.
6■m)、 2.59(2H,m)、 3.84(31
1,s)、 4.09(4tl、m)、 5.94(I
FI、 s)、 6.91(2jl、 dd)、 7.
54(2H,dd)。Molecular formula: CzsTo□O, (412) Melting point: 122
.. 0~122.4°C Infrared absorption spectrum v,,, cm-' (KBr)
:2960, 1626.1606.1558.12
52.1232°1218, 1172.1160.11
34.826 proton nuclear magnetic resonance spectrum (200M
Hz)δCDCI! (ppm, J=)Iz): 0.94 (6H, d, J・6.4), 1.31 to 1.
6 ■ m), 2.59 (2H, m), 3.84 (31
1,s), 4.09(4tl,m), 5.94(I
FI, s), 6.91 (2jl, dd), 7.
54 (2H, dd).
7.73(III、d、J・15.6)、 7.91(
IH,d、J、15.6)マススペクトルm/z(り
[EI−MS] :412(M”、 63)、 35
5(3B)、 221(100)、 165(2)4’
、6−ジェトキシ−4−メトキシ−2′−メトキシカル
ボニルメトキシ−3−イソペンチルカルコン
窒素雰囲気下、(1)で得た化合物3.0gと水素化ナ
トリウム(55%in oil)0.38gの混合物に
氷冷下でDMF 50mrをゆっくり滴下し室温に戻し
たのちに30分間撹拌した。反応混合物にα−ブロム酢
酸メチル0.85−を滴下し、更に1時間撹拌した。7.73 (III, d, J・15.6), 7.91 (
IH, d, J, 15.6) Mass spectrum m/z (Ri
[EI-MS]: 412 (M”, 63), 35
5 (3B), 221 (100), 165 (2) 4'
, 6-jethoxy-4-methoxy-2'-methoxycarbonylmethoxy-3-isopentylchalcone A mixture of 3.0 g of the compound obtained in (1) and 0.38 g of sodium hydride (55% in oil) under a nitrogen atmosphere. 50 ml of DMF was slowly added dropwise to the mixture under ice-cooling, the mixture was returned to room temperature, and then stirred for 30 minutes. 0.85-methyl α-bromoacetate was added dropwise to the reaction mixture, and the mixture was further stirred for 1 hour.
反応終了後、反応混合物に水を加え酢酸エチルで抽出し
た。抽出溶液を水洗、乾燥(無水硫酸ナトリウム)した
のちに溶媒を留去したところ、油状物として標記化合物
を4.03g得た。After the reaction was completed, water was added to the reaction mixture and extracted with ethyl acetate. After washing the extracted solution with water and drying (anhydrous sodium sulfate), the solvent was distilled off to obtain 4.03 g of the title compound as an oil.
分子式: C21H310t(484)融点: 46.
6℃
赤外線吸収スペクトルν□Xcm−’(KBr) :
2952、174B、 1662.1600.1574
.1514゜1442、 1422. 1320. 1
290. 1258. 1220゜1204、1174
.1136.1098プロトン核磁気共鳴スペクトル(
200M)Iz)δCDe13(ppm、 J=Hz
) :
0.94(611,d、J=6.6)、 1.28(
3H,t、J・6.9)。Molecular formula: C21H310t (484) Melting point: 46.
6℃ Infrared absorption spectrum ν□Xcm-' (KBr):
2952, 174B, 1662.1600.1574
.. 1514°1442, 1422. 1320. 1
290. 1258. 1220°1204, 1174
.. 1136.1098 proton nuclear magnetic resonance spectrum (
200M)Iz)δCDe13(ppm, J=Hz
): 0.94 (611, d, J=6.6), 1.28 (
3H, t, J・6.9).
1.45(3H,t、J=6.9)、 1.34〜1
.48(2tl、m)。1.45 (3H, t, J=6.9), 1.34-1
.. 48 (2tl, m).
1.58〜1.78(1■、m)、 2.60(2f
(、m)、 3.74(31t、s)、 3.83
(3H,s)、 4.00(2+1.Q、J= 6.
9)。1.58-1.78 (1■, m), 2.60 (2f
(, m), 3.74 (31t, s), 3.83
(3H,s), 4.00(2+1.Q, J=6.
9).
4.05(211,q、J= 6.9)、 4.51
(2H,s)、 6.29(IH,s)、 6.8
8(LH,d、J=15.9)、 6.88(2H,
dd。4.05 (211,q, J=6.9), 4.51
(2H, s), 6.29 (IH, s), 6.8
8 (LH, d, J = 15.9), 6.88 (2H,
dd.
J・2.0. 7.1)、 7.32(111,d、
J・15.9)、 7.46(211,dd、J=2
.0. 7.1)マススペクトルm/z(χ) [EI
−MSI :484(M”、 81)、 427(1
00)、 355(36)、 265(62)、 16
H74)、 121(87)(3)2’−カルボキシメ
トキシ−4′、6−ジェトキシ−4−メトキシ−3′−
イソペンチルカルコン
(2)で得た化合物4.03gのメタノール−ジオキサ
ン50m1溶液に5%−KOH(aq)を50mZ加え
、室温で30分間撹拌した。反応終了後、反応混合物に
水を加え希塩酸を用いて弱酸性とした後に酢酸エチルで
抽出した。抽出溶液を水洗、乾燥、濃縮した後、酢酸エ
チル−ヘキサン系で結晶化したところ淡黄色の固体とし
て標記化合物を2.54g (74%、(1)で得た
化合物からの収率)得た。J・2.0. 7.1), 7.32(111,d,
J・15.9), 7.46 (211, dd, J=2
.. 0. 7.1) Mass spectrum m/z (χ) [EI
-MSI: 484 (M”, 81), 427 (1
00), 355(36), 265(62), 16
H74), 121(87)(3) 2'-carboxymethoxy-4', 6-jethoxy-4-methoxy-3'-
To a solution of 4.03 g of the compound obtained from isopentyl chalcone (2) in 50 ml of methanol-dioxane was added 50 mZ of 5%-KOH (aq), and the mixture was stirred at room temperature for 30 minutes. After the reaction was completed, water was added to the reaction mixture, the mixture was made weakly acidic using diluted hydrochloric acid, and then extracted with ethyl acetate. The extracted solution was washed with water, dried, and concentrated, and then crystallized from an ethyl acetate-hexane system to obtain 2.54 g (74%, yield from the compound obtained in (1)) of the title compound as a pale yellow solid. .
分子式: C2?l+3407 (470)融点: 1
10.6〜111.5℃
赤外線吸収スペクトルシ□xcm−’(KBr) :
2952、1?36.1644.1602.1574.
1512゜1252、1168.1138
プロトン核磁気共鳴スペクトル(200M)Iz)δC
DCh(ppm、 J=Hz) :
0.94(6H,d、J=6.6)、 1.25(3)
1.t、J・7.0) 。Molecular formula: C2? l+3407 (470) Melting point: 1
10.6-111.5℃ Infrared absorption spectrum xcm-' (KBr):
2952, 1?36.1644.1602.1574.
1512°1252, 1168.1138 Proton nuclear magnetic resonance spectrum (200M) Iz) δC
DCh (ppm, J=Hz): 0.94 (6H, d, J=6.6), 1.25 (3)
1. t, J・7.0).
1.43(311,t、J=7.0)、 1.37〜1
.42(2H,w)。1.43 (311,t, J=7.0), 1.37~1
.. 42 (2H, w).
1.49〜1.68(IH,m)、 2.64(2H,
o+)、 3.84(3B、s)、 4.09(2H,
q、J=7.0)、 4.14(2H,q。1.49-1.68 (IH, m), 2.64 (2H,
o+), 3.84 (3B, s), 4.09 (2H,
q, J=7.0), 4.14 (2H, q.
7.0)、 4.50(lH,s)、 6.53(lt
l、s)、 6.93(lIl、d、J=16.1)、
6.96(2H,dd、J=1.9.6.8)。7.0), 4.50(lH,s), 6.53(lt
l, s), 6.93 (lIl, d, J=16.1),
6.96 (2H, dd, J=1.9.6.8).
7.34(III、d、 J、16.1)、 7.59
(2H,dd、J=1.9゜6.8)
マススペクトルmHz(χ) [EI−貼コ :470
(M”、 86)、 413(78)、 355(45
)、 221(76)、193(71)、16H59)
、121(100)元素分析:
計算値、 C: 68.92 旧7.28実測値;
C: 69.10 It: 7.25実施例10
2−カルボキシメトキシ−4−エトキシ−4′。7.34 (III, d, J, 16.1), 7.59
(2H, dd, J = 1.9°6.8) Mass spectrum mHz (χ) [EI-Packing: 470
(M”, 86), 413 (78), 355 (45
), 221(76), 193(71), 16H59)
, 121 (100) Elemental analysis: Calculated value, C: 68.92 Old 7.28 actual value;
C: 69.10 It: 7.25 Example 10 2-Carboxymethoxy-4-ethoxy-4'.
6′−ジメトキシ−3′−イソペンチルカルコン(1)
4−エトキシ−2′−ヒドロキシ−4’、6’−ジメト
キシ−3′−イソペンチルカルコン2’、4’、6’−
トリヒドロキシ−3−(3−メチル−2−ブテニル)ア
セトフヱノン25.0gと炭酸カリウム45.0gとの
アセトン(200tai )懸濁溶液に、ジメチル硫酸
22.0gを加え20時間撹拌した。反応終了後、固体
を除去し、濾液を濃縮した。析出した固体を冷メタノー
ルで数回洗浄したところ、下記の化合物を白色の粉体と
して、19.0g(67%)得た。6'-dimethoxy-3'-isopentyl chalcone (1)
4-ethoxy-2'-hydroxy-4', 6'-dimethoxy-3'-isopentyl chalcone 2', 4', 6'-
To a suspension of 25.0 g of trihydroxy-3-(3-methyl-2-butenyl)acetophenone and 45.0 g of potassium carbonate in acetone (200 ml), 22.0 g of dimethyl sulfuric acid was added and stirred for 20 hours. After the reaction was completed, the solids were removed and the filtrate was concentrated. When the precipitated solid was washed several times with cold methanol, 19.0 g (67%) of the following compound was obtained as a white powder.
4′、6−シメトキシー2−ヒドロキシ−3−(3−メ
チル−2−ブテニル)アセトフェノン次に、予め水素゛
を吸着させたPd−C(5%)3.0gの酢酸エチル(
400rd)懸濁液に上記化合物19.0gの酢酸エチ
ル溶液を加え、更に水素を吸着させた。4',6-Simethoxy 2-hydroxy-3-(3-methyl-2-butenyl)acetophenone Next, 3.0 g of Pd-C (5%) to which hydrogen had been adsorbed in advance and ethyl acetate (
400rd) A solution of 19.0 g of the above compound in ethyl acetate was added to the suspension to further adsorb hydrogen.
反応終了後、セライトを用いてPd−Cを除き、減圧下
で溶液を留去した。残留物にヘキサンを加え結晶化した
ところ下記の化合物を、白色の針状晶として17.4g
(91%)得た。After the reaction was completed, Pd-C was removed using Celite, and the solution was distilled off under reduced pressure. When hexane was added to the residue and crystallized, 17.4g of the following compound was obtained as white needle-like crystals.
(91%) obtained.
2′−ヒドロキシ−4’、6’−ジメトキシ−3−イソ
ペンチルアセトフェノン
そして、上記で得た化合物2.0gとp−エトキシベン
ズアルデヒド1.1gのエタノール−ジメチルスルホキ
シド混合(20rol)溶液に、撹拌しながら、飽和水
酸化カリウム−エタノール溶液を20−加え室温で20
時間撹拌した。反応終了後、反応混合物に希塩酸を加え
弱酸性にしたのち析出した固体を濾取した。沈澱物を酢
酸エチルで溶解したのち、水洗、乾燥し続いて溶媒を留
去した。濃縮物を酢酸エチル−石油エーテル系で結晶化
したところ、赤橙色の針状晶として標記化合物を2.5
6g(85%)得た。2'-Hydroxy-4',6'-dimethoxy-3-isopentylacetophenone and a mixed solution of 2.0 g of the compound obtained above and 1.1 g of p-ethoxybenzaldehyde in ethanol-dimethyl sulfoxide (20 rolls) were stirred. At room temperature, add 20% of saturated potassium hydroxide-ethanol solution.
Stir for hours. After the reaction was completed, dilute hydrochloric acid was added to the reaction mixture to make it slightly acidic, and the precipitated solid was collected by filtration. The precipitate was dissolved in ethyl acetate, washed with water, dried, and then the solvent was distilled off. When the concentrate was crystallized in an ethyl acetate-petroleum ether system, the title compound was crystallized as red-orange needle-like crystals.
6g (85%) obtained.
分子式:Cz<IIs。o、 (398)融点7131
.7〜132.1°C
赤外線吸収スペクトルV @mxcl−’(KBr)
:2948、1632.1606.1582.155
4.1512゜1472.1424,1304,128
8.1260,1230゜1174. 1148. 1
140. 824プロトン核磁気共鳴スペクトル(20
0MHz)δCDCl *(ppm、 J=Hz)
:
0.94(611,d、J・6.4)、 1.43(t
、J・7.0)、 1.33〜1.61(n+)、 2
.58(2H,m)、 3.88(3)1. s)。Molecular formula: Cz<IIs. o, (398) melting point 7131
.. 7-132.1°C Infrared absorption spectrum V @mxcl-' (KBr)
:2948, 1632.1606.1582.155
4.1512°1472.1424,1304,128
8.1260,1230°1174. 1148. 1
140. 824 proton nuclear magnetic resonance spectrum (20
0MHz) δCDCl*(ppm, J=Hz)
: 0.94 (611, d, J・6.4), 1.43 (t
, J・7.0), 1.33-1.61(n+), 2
.. 58 (2H, m), 3.88 (3) 1. s).
3.94(3H,s)、 4.06(2H,q、J=6
.8)、 5.98(IH,s)、 6.90<2H,
dd)、 7.54(2H,dd、J=2.2.6.8
)、 7.76(2H,s)マススペクトルm/z(り
[EI−MS] :398(M”、 5B)、 3
41(31)、 193(100)。3.94 (3H, s), 4.06 (2H, q, J=6
.. 8), 5.98 (IH, s), 6.90<2H,
dd), 7.54 (2H, dd, J=2.2.6.8
), 7.76 (2H, s) mass spectrum m/z (ri [EI-MS]: 398 (M", 5B), 3
41(31), 193(100).
(2)4−エトキシ−4’、6’−ジメトキシ−2−メ
トキシカルボニルメトキシ−3′−イソペンチルカルコ
ン
C00CHx
(1)で得た化合物15.0 g、無水炭酸カリウム7
.76gとヨウ化カリウム1.5gのoMF(15(I
n/)溶液を窒素雰囲気下、室温で45分間撹拌した。(2) 4-ethoxy-4',6'-dimethoxy-2-methoxycarbonylmethoxy-3'-isopentylchalcone C00CHx 15.0 g of the compound obtained in (1), 7 g of anhydrous potassium carbonate
.. 76 g and 1.5 g of potassium iodide oMF (15(I)
n/) solution was stirred at room temperature for 45 minutes under nitrogen atmosphere.
続いて反応混合物に、ブロム酢酸メチルを4.3 d滴
下し、更に三日間撹拌した。反応終了後、反応混合物に
水を加え酢酸エチルで抽出した。抽出溶液を水洗、乾燥
(無水硫酸ナトリウム)したのちに溶媒に留去し、酢酸
エチル−ジエチルエーテル・−ヘキサン系で結晶化した
ところ、淡黄色の固体として標記化合物を16.1’g
(91%)得た。Subsequently, 4.3 d of methyl bromoacetate was added dropwise to the reaction mixture, and the mixture was further stirred for three days. After the reaction was completed, water was added to the reaction mixture and extracted with ethyl acetate. The extracted solution was washed with water and dried (anhydrous sodium sulfate), then distilled into a solvent and crystallized from an ethyl acetate-diethyl ether-hexane system, yielding 16.1'g of the title compound as a pale yellow solid.
(91%) obtained.
分子式: CztlhaOt(470)融点789.9
〜90,8°C
赤外線吸収スペクトルν□xcm−’(KBr) :
2952、1738.1642.1602.1572.
1514゜1462、 1318. 1276、 12
52. 1200. 11B0゜1158、1130.
1102.1076、1044プロトン核磁気共鳴スペ
クトル(200MHz)δCDe13(ppm、 J=
Hz) :
0.94(61(、d、J・6.6)、 1.42(3
Lの・7.0)。Molecular formula: CztlhaOt (470) Melting point 789.9
~90,8°C Infrared absorption spectrum ν□xcm-' (KBr):
2952, 1738.1642.1602.1572.
1514°1462, 1318. 1276, 12
52. 1200. 11B0゜1158, 1130.
1102.1076, 1044 proton nuclear magnetic resonance spectrum (200MHz) δCDe13 (ppm, J=
Hz): 0.94(61(,d,J・6.6), 1.42(3
L's 7.0).
1.35〜1.45(2tl、m)、 1.58〜1.
67(IH,m)。1.35-1.45 (2 tl, m), 1.58-1.
67 (IH, m).
2.59(2B、m)、 3.72(3H,s)、
3.78(38,s)。2.59 (2B, m), 3.72 (3H, s),
3.78 (38,s).
3.87(311,s)、 4.05(2H,q、J
=7.0)、 4.49(2tl、s)、 6.3
2(IH,s)、 6.86(2tl、dd、J=1
.9゜6.7)、 6.87(IH,dd、J・15
.9)、 7.32(IH,d。3.87 (311, s), 4.05 (2H, q, J
=7.0), 4.49 (2tl, s), 6.3
2 (IH, s), 6.86 (2tl, dd, J=1
.. 9°6.7), 6.87 (IH, dd, J・15
.. 9), 7.32 (IH, d.
J=15.9)、 7.46(2u、aa、、y・1
.9. 6.7)マススペクトルm/z(χ) [Er
−?lS] :470(M”、38)、452(55
)、411(100)、193(70)、 175(
44)、 135(41)(3)2−カルボキシメト
キシ−4−エトキシ−4’、6’−ジメトキシ−3′−
イソペンチルカルコン
(2)で得た化合物を実施例9(3)と同様の方法で処
理して、標記化合物を収率74%((1)で得た化合物
からの収率)で得た。J=15.9), 7.46(2u, aa,,y・1
.. 9. 6.7) Mass spectrum m/z (χ) [Er
−? lS]: 470 (M”, 38), 452 (55
), 411(100), 193(70), 175(
44), 135(41)(3) 2-carboxymethoxy-4-ethoxy-4',6'-dimethoxy-3'-
The compound obtained with isopentyl chalcone (2) was treated in the same manner as in Example 9 (3) to obtain the title compound in a yield of 74% (yield from the compound obtained in (1)).
分子式: CzhHzzOl(456)融点: 145
.7〜146.4°C
赤外線吸収スペクトルv mmxcm−’ (KBr)
:2952、 166B、 1600.1260
. 1202. 1138プロトン核磁気共鳴スペクト
ル(200MHz)δCDCh(ppm、 J=Hz)
:
0.93(611,d、J=6.6)、 1.37(
t、J・6.9)、 1.43〜1.47(m)、
1.5〜1.6(IH,+++)、 2.63(2
H,n+)。Molecular formula: CzhHzOl (456) Melting point: 145
.. 7-146.4°C Infrared absorption spectrum v mmxcm-' (KBr)
:2952, 166B, 1600.1260
.. 1202. 1138 proton nuclear magnetic resonance spectrum (200MHz) δCDCh (ppm, J=Hz)
: 0.93 (611, d, J=6.6), 1.37 (
t, J・6.9), 1.43-1.47(m),
1.5-1.6 (IH, +++), 2.63 (2
H, n+).
3.81(3H,s)、 3.93(3H,s)、
4.09(2H,q、J=6.9)、 4.48(
28,s)、 6.59(IH,s)、 6.90
(ill、d、J・16.1)、 6.94(2H,
dd、J=2.0. 6.8)。3.81 (3H, s), 3.93 (3H, s),
4.09 (2H, q, J = 6.9), 4.48 (
28,s), 6.59(IH,s), 6.90
(ill, d, J・16.1), 6.94 (2H,
dd, J=2.0. 6.8).
7.32(18,d、J・16.1)、 7.57
(2H,dd、J、1.7゜6゜8)
マススペクトルI11/2(χ) [EI−MS]
:456(M”、51)、411(58)、399(4
1)、193(100)、135(47)
元素分析:
計算値、 C: 68.40 H: 7.07実測値
; C: 6B、17 H: 7.00実施例11
1−(4,6−シヒドロキシー2−メトキシカルボニル
メトキシフェニル)−3−(4−ヒドロキシフェニル)
−1−プロパノン
(1)l−(2−メトキシカルボニルメトキシ−4,6
−ビス(メトキシメトキシ)フェニル〕−3−(4−メ
トキシフェニル)−1−プロパノン
2’、4’、6′−トリヒドロキシアセトフェノン2.
0gとN、N−ジイソプロピルエチルアミン8.3−の
TIIF(10+nZ)溶液ニー20′cテクロロメチ
ルメチルエーテル3.61m1をゆっくり滴下し30分
間撹拌したのちに更に室温に戻して2時間撹拌した。反
応終了後、反応混合物に水を加え、ジエチルエーテルで
抽出した。抽出溶液を水洗、乾燥(無水硫酸ナトリウム
)、濃縮したのちにジエチルエーテル−ヘキサン系で結
晶化したところ、白色固体として下記の化合物を2.3
h(75%)得た。7.32 (18, d, J・16.1), 7.57
(2H, dd, J, 1.7°6°8) Mass spectrum I11/2 (χ) [EI-MS]
:456 (M”, 51), 411 (58), 399 (4
1), 193 (100), 135 (47) Elemental analysis: Calculated value, C: 68.40 H: 7.07 Actual value; C: 6B, 17 H: 7.00 Example 11 1-(4,6 -cyhydroxy-2-methoxycarbonylmethoxyphenyl)-3-(4-hydroxyphenyl)
-1-propanone (1) l-(2-methoxycarbonylmethoxy-4,6
-Bis(methoxymethoxy)phenyl]-3-(4-methoxyphenyl)-1-propanone2',4',6'-trihydroxyacetophenone2.
0 g of N,N-diisopropylethylamine 8.3- in TIIF (10+nZ) solution (3.61 ml) of 20'c tetrachloromethyl methyl ether was slowly added dropwise and stirred for 30 minutes, then the mixture was further warmed to room temperature and stirred for 2 hours. After the reaction was completed, water was added to the reaction mixture, and the mixture was extracted with diethyl ether. The extracted solution was washed with water, dried (anhydrous sodium sulfate), concentrated, and then crystallized with diethyl ether-hexane system, resulting in the following compound as a white solid with 2.3
h (75%) was obtained.
2′−ヒドロキシ−4’、6’−ビス(メトキシメトキ
シ)アセトフェノン
一方、p−ヒドロキシヘンズアルデヒド15gとN、N
−ジイソプロピルエチルアミン31.7mZのDMF(
100m/)溶液に水冷下でクロロメチルメチルエーテ
ル13.5mlを滴下したのちに室温で3時間撹拌した
。反応終了後、反応混合物に水を加え、ジエチルエーテ
ルで抽出した。抽出溶液を水洗、乾燥(無水硫酸ナトリ
ウム)したのちに溶媒を留去し、減圧下で乾燥したとこ
ろ、無色透明の油状物として下記の化合物を18.8g
(94%)得た。2'-hydroxy-4',6'-bis(methoxymethoxy)acetophenone, while 15 g of p-hydroxyhenzaldehyde and N,N
-diisopropylethylamine 31.7mZ in DMF (
13.5 ml of chloromethyl methyl ether was added dropwise to the 100 m/) solution under water cooling, and the mixture was stirred at room temperature for 3 hours. After the reaction was completed, water was added to the reaction mixture, and the mixture was extracted with diethyl ether. After washing the extracted solution with water and drying (anhydrous sodium sulfate), the solvent was distilled off and dried under reduced pressure, yielding 18.8 g of the following compound as a colorless and transparent oil.
(94%) obtained.
p−メトキシメトキシベンズアルデヒド上記によって得
たアセトフェノン誘導体15.0gとベンズアルデヒド
誘導体14.7gのエタノール(100mf)溶液に、
撹拌しながら飽和水酸化カリウム−エタノール溶液を1
20mf加え、室温で16時間撹拌した。反応混合物を
冷水中に注ぎ、希塩酸で弱酸性にしたのちに析出した固
体を濾取した。濾過物を減圧乾燥し、シリカゲルカラム
クロマトグラフィー(溶離剤;酢酸エチル:ヘキサン=
l:3)で分離精製した。続いて、溶媒を留去したのち
に、酢酸エチル−ジエチルエーテル−ヘキサン系で結晶
化したところ、赤橙色の板状結晶として下記の化合物を
18.0g(75%)得た。p-Methoxymethoxybenzaldehyde In an ethanol (100 mf) solution of 15.0 g of the acetophenone derivative obtained above and 14.7 g of the benzaldehyde derivative,
While stirring, add 1 liter of saturated potassium hydroxide-ethanol solution.
20 mf was added and stirred at room temperature for 16 hours. The reaction mixture was poured into cold water, made weakly acidic with dilute hydrochloric acid, and the precipitated solid was collected by filtration. The filtrate was dried under reduced pressure and subjected to silica gel column chromatography (eluent; ethyl acetate:hexane=
1:3). Subsequently, after distilling off the solvent, crystallization was performed using an ethyl acetate-diethyl ether-hexane system to obtain 18.0 g (75%) of the following compound as red-orange plate crystals.
2′−ヒドロキシ−4,4’、6’−)リス (メトキ
シメトキシ)カルコン ゛
予め水素を吸着させた5%Pd−C2,5gの酢酸エチ
ル(380d)懸濁液に上記化合物17.0gの酢酸エ
チル溶液を加え、更に水素を吸着させた。反応終了後、
セライトを用いてPd−Cを除き、減圧下で溶媒を留去
した。残留物を冷凍庫中に放置しておいたところ、白色
の固体として下記の化合物を16.7g(98%)得た
。2'-Hydroxy-4,4',6'-)lis(methoxymethoxy)chalcone 17.0g of the above compound was added to a suspension of 5% Pd-C2, 5g in ethyl acetate (380d) on which hydrogen had been adsorbed in advance. Ethyl acetate solution was added to further adsorb hydrogen. After the reaction is complete,
Pd-C was removed using Celite, and the solvent was distilled off under reduced pressure. The residue was left in the freezer, yielding 16.7 g (98%) of the following compound as a white solid.
1(2−ヒドロキシ−4,6−ビス (メトキシメトキ
シフェニル〕−3−(4−メトキシメトキシフェニル)
〜1−プロパノン
上記で得た化合物2.0g、炭酸カリウム(無水)1.
4gとヨウ化カリウム0.28のD?lF (20rn
l)溶液を窒素雰囲気下、室温で70分間撹拌した。続
いて反応混合物にα−ブロム酢酸メチル0.56m#を
加え、更に5時間撹拌した。反応終了後、反応混合物に
水を加え、ジエチルエーテルで抽出した。抽出溶液を水
洗、乾燥(無水硫酸ナトリウム)したのちに溶媒を留去
し、酢酸エチル−石油エーテル−ヘキサン系で結晶化し
たところ、白色固体として標記化合物を2.14g(9
1%)得た。1(2-hydroxy-4,6-bis(methoxymethoxyphenyl)-3-(4-methoxymethoxyphenyl)
~1-Propanone 2.0 g of the compound obtained above, potassium carbonate (anhydrous) 1.
4g and potassium iodide 0.28 D? IF (20rn
l) The solution was stirred for 70 minutes at room temperature under nitrogen atmosphere. Subsequently, 0.56 m# of methyl α-bromoacetate was added to the reaction mixture, and the mixture was further stirred for 5 hours. After the reaction was completed, water was added to the reaction mixture, and the mixture was extracted with diethyl ether. After washing the extracted solution with water and drying (anhydrous sodium sulfate), the solvent was distilled off and crystallized from an ethyl acetate-petroleum ether-hexane system, yielding 2.14 g (9.9 g) of the title compound as a white solid.
1%) obtained.
分子式: CBtlzsO+。(464)融点: 49
.0〜50.0°C
赤外線吸収スペクトル1/ IIIIMCIll−’
(KBr) :2952、1750.170B、 1
614.1592.122B。Molecular formula: CBtlzsO+. (464) Melting point: 49
.. 0~50.0°C Infrared absorption spectrum 1/IIIMCIll-'
(KBr) :2952, 1750.170B, 1
614.1592.122B.
1218、1152.1134.10B6.1038.
1016プロトン核磁気共鳴スペクトル(200Mz)
δppmJ9□、(CDCI、) 。1218, 1152.1134.10B6.1038.
1016 proton nuclear magnetic resonance spectrum (200Mz)
δppmJ9□, (CDCI,).
62.93〜3.02(2H,m) 、 63.09
〜3.17(21+。62.93-3.02 (2H, m), 63.09
~3.17 (21+.
m)、 63.41 (3H,S) 、 δ3.4
6,3.46.δ3.77(311,S)、 δ4.
57 (21+ 、 S’) 、 65.07(2H
,S) 。m), 63.41 (3H,S), δ3.4
6, 3.46. δ3.77 (311, S), δ4.
57 (21+, S'), 65.07 (2H
,S).
δ5.12(2+1.S)、δ5.14(2H,S)、
66.17(III。δ5.12 (2+1.S), δ5.14 (2H,S),
66.17 (III.
d、J・2.0)、 66.49(Ill、d、J=
2.0)、 δ6.95C2H,dd、J=2.0.
6.6)、 67.15(211,dd、 J・2.
0. 6.6)
(2)1−(4,6−シヒドロキシー2−メトキシカル
ボニルメトキシフェニル)−3−(4−ヒドロキシフェ
ニル)−1−プロパノン(1)で得た化合物2.0gの
メタノール(20+n/ )溶液に(80〜90%)塩
酸−メタノール溶液15/を加え、撹拌しながら20分
間加温(水浴中45〜50°C)した。反応終了後、反
応混合物を室温に戻したのちに、水を加え、析出した固
体を濾取した。濾過物を減圧下で乾燥したのちに、メタ
ノール−クロロホルム−ヘキサン系で再結晶したところ
、白色の粉体として標記化合物を1.41g(97%)
得た。d, J・2.0), 66.49 (Ill, d, J=
2.0), δ6.95C2H, dd, J=2.0.
6.6), 67.15 (211, dd, J.2.
0. 6.6) (2) 2.0 g of the compound obtained with 1-(4,6-cyhydroxy-2-methoxycarbonylmethoxyphenyl)-3-(4-hydroxyphenyl)-1-propanone (1) in methanol (20+n/ ) To the solution (80-90%) hydrochloric acid-methanol solution 15/1 was added and heated (45-50°C in a water bath) for 20 minutes while stirring. After the reaction was completed, the reaction mixture was returned to room temperature, water was added, and the precipitated solid was collected by filtration. After drying the filtrate under reduced pressure, it was recrystallized from a methanol-chloroform-hexane system, yielding 1.41 g (97%) of the title compound as a white powder.
Obtained.
分子式: CIaH+ sO+ (346)融点719
8.5〜199.0°C
赤外線吸収スペクトルシsmxCm−’ (にBr)
:343B、 1730.1622.1514.13
72.1310゜プロトン核磁気共鳴スペクトル(20
0MZ)δ(Acetone−d) :
62.89(2H,t、J・7.8)、 63.43
(2B、 t、 J・7.8)、 63.70(3H
,S) 、 δ4.83(2+1.S)、 δ5.
94(IH,d、J=2.5)、 66.00(Il
l、d、r・2.5)。Molecular formula: CIaH+ sO+ (346) Melting point 719
8.5-199.0°C Infrared absorption spectrum smxCm-' (Br)
:343B, 1730.1622.1514.13
72.1310° proton nuclear magnetic resonance spectrum (20
0MZ) δ (Acetone-d): 62.89 (2H, t, J・7.8), 63.43
(2B, t, J・7.8), 63.70 (3H
,S), δ4.83(2+1.S), δ5.
94 (IH, d, J = 2.5), 66.00 (Il
l, d, r・2.5).
66.75(2H,dd、J・2.4.6.8)、67
、10 (2H,dd)マススペクトルm/z(χ):
346(M” 、 19)、 225(30)、 19
7(31)。66.75 (2H, dd, J・2.4.6.8), 67
, 10 (2H, dd) mass spectrum m/z (χ): 346 (M”, 19), 225 (30), 19
7 (31).
実施例12
■−(2−カルボキシメトキシ−4,6−シヒドロキシ
フエニル)−3−(4−ヒドロキシフェニル)−1−プ
ロパノン
OOH
実、施例11で得た化合物50■のメタノール(1,5
m1)溶液に5%水酸化カリウム水溶液0.5−を加え
、室温で15分間撹拌した。反応終了後、反応混合物に
水を加え、希塩酸を用いて弱酸性に溶液を調節したのち
に析出した固体を濾取した。濾別した固体を減圧下で加
熱、乾燥したのちに、メタノール−クロロホルム−ヘキ
サン系で再結晶化したところ白色の粉体として標記化合
物を29■得た。Example 12 ■-(2-Carboxymethoxy-4,6-cyhydroxyphenyl)-3-(4-hydroxyphenyl)-1-propanone OOH Actually, methanol (1, 5
m1) To the solution was added 0.5% of a 5% aqueous potassium hydroxide solution, and the mixture was stirred at room temperature for 15 minutes. After the reaction was completed, water was added to the reaction mixture, the solution was adjusted to be slightly acidic using diluted hydrochloric acid, and the precipitated solid was collected by filtration. The filtered solid was heated and dried under reduced pressure, and then recrystallized from a methanol-chloroform-hexane system to obtain 29 ml of the title compound as a white powder.
分子式: CI J+ act (332)融点: 2
35.5〜237.0℃
赤外線吸収スペクトルv maxCm−’ (KBr)
:3408、1?42.1632.1600.15
14.1454゜1252、1210.1180
プロトン核磁気共鳴スペクトル(200MZ)δppm
。Molecular formula: CI J+ act (332) Melting point: 2
35.5-237.0°C Infrared absorption spectrum v maxCm-' (KBr)
:3408, 1?42.1632.1600.15
14.1454°1252, 1210.1180 Proton nuclear magnetic resonance spectrum (200MZ) δppm
.
J=H2,(Acet、one−d) :62.90(
2H,t、J=8.1)、δ3.46(21,t、J・
8.1) 。J=H2, (Acet, one-d): 62.90 (
2H, t, J = 8.1), δ3.46 (21, t, J
8.1).
64.83(2+1. S) 、 δ5.97(II
I、d、J=2.3)、 66.0(LH,d、J・
2.3)、 66.73(21+、 dd、 J・2
.1゜6.4)、 67.10(211,dd、J・
2.1.6.4)マススペクトルm/z(χ):
332(M ” 、 21)、 211(26)、 1
53(61)。64.83(2+1.S), δ5.97(II
I, d, J = 2.3), 66.0 (LH, d, J.
2.3), 66.73 (21+, dd, J・2
.. 1゜6.4), 67.10 (211, dd, J.
2.1.6.4) Mass spectrum m/z (χ): 332 (M'', 21), 211 (26), 1
53(61).
実施例13
1−(4,6−シヒドロキシー2−メトキシカルボニル
メトキシフェニル)、−3−(3,4−ジヒドロキシフ
ェニル)−1−プロパノン
C00CI+。Example 13 1-(4,6-Sihydroxy-2-methoxycarbonylmethoxyphenyl), -3-(3,4-dihydroxyphenyl)-1-propanone C00CI+.
(1)1−(2−メトキシカルボニルメトキシ−4,6
−ビス(メトキシメトキシフェニル)〕−3−(3,4
−ビス (メトキシメトキシフェニル)〕−〕1−プロ
パノ
ン素気流下、■−〔2−ヒドロキシ−4,6−ビス〔メ
トキシメトキシフェニル)−3−(3,4−ビス(メト
キシメトキシフェニル)]−]1−プロパノン121g
と水素化ナトリウム1.50gの混合物に水冷下で、D
MF 100mfをゆっくり滴下し、室温に戻したのち
に30分間撹拌した。次に反応混合物に室温下でα−ブ
ロム酢酸メチル3. Ornlを加え更に60分間撹拌
した。反応終了後、反応混合物に水を加え、酢酸エチル
で抽出したのちにカラムクロマトグラフィー(シリカゲ
ルMerck 9385、溶離剤;酢酸エチル:ヘキサ
ン−1:4)で分離、精製した。溶媒留去後、濃縮物を
酢酸エチル−石油エーテル−ヘキサン系で結晶化したと
ころ、白色の粉体として標記化合物を12.6g(90
%)得た。(1) 1-(2-methoxycarbonylmethoxy-4,6
-bis(methoxymethoxyphenyl)]-3-(3,4
-Bis(methoxymethoxyphenyl)]-]Under a stream of 1-propanone, ■-[2-hydroxy-4,6-bis[methoxymethoxyphenyl)-3-(3,4-bis(methoxymethoxyphenyl)]- ]1-propanone 121g
D to a mixture of 1.50 g of sodium hydride and 1.50 g of sodium hydride under water cooling.
MF 100mf was slowly added dropwise, the temperature was returned to room temperature, and the mixture was stirred for 30 minutes. Next, add 3.5% of methyl α-bromoacetate to the reaction mixture at room temperature. Ornl was added and stirred for an additional 60 minutes. After the reaction was completed, water was added to the reaction mixture, and the mixture was extracted with ethyl acetate, and then separated and purified by column chromatography (silica gel Merck 9385, eluent: ethyl acetate:hexane-1:4). After evaporation of the solvent, the concentrate was crystallized with ethyl acetate-petroleum ether-hexane system, and 12.6 g (90 g) of the title compound was obtained as a white powder.
%)Obtained.
分子式: CzJznO,z(522)融点: 68.
5〜69.0°C
赤外線吸収スペクトルν□Xcm−’ (KBr)
:1760、1708.1608.1594.1512
.1256゜1150、1126.1084.103B
、 1012.1002プロトン核磁気共鳴スペクトル
(200MZ)δppm。Molecular formula: CzJznO,z (522) Melting point: 68.
5~69.0°C Infrared absorption spectrum ν□Xcm-' (KBr)
:1760, 1708.1608.1594.1512
.. 1256°1150, 1126.1084.103B
, 1012.1002 proton nuclear magnetic resonance spectrum (200MZ) δppm.
J□z、(CDCh) :
63.09〜3.18(2H,m) 、 62.96
〜3.00(211゜m)、δ3.42(3)1.S)
、63.46 (3H、S) 、δ3.50(311、
S) 、 63.76 (、TI 、 S) 、
δ4.59(2H,S)。J□z, (CDCh): 63.09-3.18 (2H, m), 62.96
~3.00 (211°m), δ3.42 (3) 1. S)
, 63.46 (3H, S), δ3.50 (311,
S), 63.76 (,TI,S),
δ4.59 (2H, S).
65.09<2H,S)、 δ5.12(2+1.
S) 、 δ5.l8(2H,S)、 δ5.20
(2H,S)、 66.17(IH,d、J・2.0
)、 66.50(111,d、J・2.0)、
66.83(IH。65.09<2H,S), δ5.12(2+1.
S), δ5. l8(2H,S), δ5.20
(2H, S), 66.17 (IH, d, J・2.0
), 66.50 (111, d, J・2.0),
66.83 (IH.
dd、J=2.0. 8.3)、 67.03(IH
,d、J=2.0) 。dd, J=2.0. 8.3), 67.03 (IH
, d, J=2.0).
67.04(IH,d、J・8.3)
(2)1−(4,6−シヒドロキシー2−メトキシカル
ボニルメトキシフェニル)−3−(3,4−ジヒドロキ
シフェニル)−1−プロパノン(1)で得た化合物3.
8gのメタノール(80m! )溶液に塩酸−メタノー
ル溶液50−を加え40〜50’C(湯浴中)加温し約
20分間撹拌した。反応終了後、反応混合物を水の中に
注ぎ析出した固体を濾取した。次に濾別した固体を酢酸
エチルで溶解し、水洗、乾燥(無水硫酸ナトリウム)し
たのち減圧下で濃縮した。残留物を酢酸エチル−石油エ
ーテルで結晶化したところ、白色の固体として標記化合
物を2.07g(81%)得た。67.04 (IH, d, J・8.3) (2) 1-(4,6-cyhydroxy-2-methoxycarbonylmethoxyphenyl)-3-(3,4-dihydroxyphenyl)-1-propanone (1) Compound 3 obtained in
A 50% hydrochloric acid-methanol solution was added to a solution of 8 g of methanol (80 m!), heated to 40-50'C (in a hot water bath), and stirred for about 20 minutes. After the reaction was completed, the reaction mixture was poured into water and the precipitated solid was collected by filtration. Next, the filtered solid was dissolved in ethyl acetate, washed with water, dried (anhydrous sodium sulfate), and concentrated under reduced pressure. The residue was crystallized from ethyl acetate-petroleum ether to yield 2.07 g (81%) of the title compound as a white solid.
分子式: c、@n、aos(362)融点: 170
.5〜171.5°C
赤外線吸収スペクトルシmaMCm−’ (にBr)
:3504、 3428. 3244. 1722.
1632. 1598゜1526、 144B、
1432. 1316. 1202. 1158゜11
28.1108
プロトン核磁気共鳴スペクトル(200MZ)δppn
+。Molecular formula: c, @n, aos (362) Melting point: 170
.. 5-171.5°C Infrared absorption spectrum smaMCm-' (Br)
:3504, 3428. 3244. 1722.
1632. 1598°1526, 144B,
1432. 1316. 1202. 1158°11
28.1108 Proton nuclear magnetic resonance spectrum (200MZ) δppn
+.
J H2,(Ac6ton−d) :62.84(2
11,t、J・8.1)、63.39(2tf、 t、
J・8.1)。J H2, (Ac6ton-d): 62.84 (2
11, t, J・8.1), 63.39 (2tf, t,
J.8.1).
63.69(311,S) 、 δ4.82(2H,
S) 、 δ5.93(III。63.69 (311, S), δ4.82 (2H,
S), δ5.93 (III.
d、J・2.3)、 66.00(lILd、J・2
.3)、 66.59(lH,dd、J・8.1.2
.1)、δ6.72(1)1. d、 J・8.1)
。d, J・2.3), 66.00(lILd, J・2
.. 3), 66.59 (lH, dd, J・8.1.2
.. 1), δ6.72(1)1. d, J・8.1)
.
δ6.76(IFI、d、J・2.1)マススペクトル
m/z(χ):
367(M” 、 48)、 225(53)、 19
7(46)。δ6.76 (IFI, d, J・2.1) Mass spectrum m/z (χ): 367 (M”, 48), 225 (53), 19
7 (46).
実施例14
4.4′−ジヒドロキシ−2−メトキシ力ルポニルメト
キシカルコン
(1)2′−メトキシカルボニルメトキシ−4,4=ビ
ス (メトキシメトキシ)カルコン
2’、4’−ジヒドロキシアセトフェノン25gのD?
IP(280mZ) ?g液に、N、N−ジイソプロピ
ルエチルアミンテル13.6m!をゆっくり滴下し更に
室温に戻し3時間撹拌した.反応終了後、反応混合物に
多量の水を加え、ジエチルエーテルで抽出した。抽出溶
液を水洗、乾燥(無水硫酸ナトリウム)したのちに減圧
下で溶媒を留去し、乾燥したところ濃赤橙色の油状物と
して、下記の化合物をほぼ定量的に得た。Example 14 4.4'-dihydroxy-2-methoxyluponylmethoxychalcone (1) 2'-methoxycarbonylmethoxy-4,4=bis(methoxymethoxy)chalcone 25 g of 2',4'-dihydroxyacetophenone D?
IP (280mZ)? 13.6 m of N,N-diisopropylethylamine ter in solution g! was slowly added dropwise, and the mixture was allowed to warm to room temperature and stirred for 3 hours. After the reaction was completed, a large amount of water was added to the reaction mixture, and the mixture was extracted with diethyl ether. After washing the extracted solution with water and drying (anhydrous sodium sulfate), the solvent was distilled off under reduced pressure and dried to obtain the following compound almost quantitatively as a deep red-orange oil.
2′−ヒドロキシ−4′−メトキシメトキシアセトフェ
ノン
上記化合物30. 14gと4−メトキシメトキシベン
ズアルデヒド25.1gのDMSO (too mり溶
液に、飽和水酸化カリウム−エタノール溶液を200
mf加え、12時間撹拌した。次に反応混合物に冷却下
で希塩酸(3規定程度)を加え、中性溶液としたのちに
、析出した固体を濾取し、減圧下で乾燥した。乾燥した
固体をカラムクロマトグラフィー(シリカゲル、Mer
ck 9385、溶離剤酢酸エチル:ヘキサン=1:1
)で分離精製したのちに、酢酸エチル−石油エーテルで
結晶化したところ、下記の化合物を25、5g(49%
)得た。2'-Hydroxy-4'-methoxymethoxyacetophenone The above compound 30. To a solution of 14 g of 4-methoxymethoxybenzaldehyde and 25.1 g of DMSO (too much), add 200 g of saturated potassium hydroxide-ethanol solution.
mf was added and stirred for 12 hours. Next, dilute hydrochloric acid (approximately 3N) was added to the reaction mixture under cooling to make a neutral solution, and the precipitated solid was collected by filtration and dried under reduced pressure. The dried solid was subjected to column chromatography (silica gel, Mer
ck 9385, eluent ethyl acetate:hexane=1:1
) and then crystallized with ethyl acetate-petroleum ether, yielding 25.5 g (49%) of the following compound.
)Obtained.
2−ヒドロキシ−4,4′−ビス (メトキシメトキシ
)カルコン
上記で得た化合物10.0g,無水炭酸カリウム6、0
gとヨウ化カリウム1.0gのDMF(100ml)溶
液を室温で60分間撹拌したのちに、α−ブロム酢酸メ
チル3.3dを加え更に4時間撹拌した。反応終了後、
反応混合物に水を加え、析出した固体を濾取した。2-Hydroxy-4,4'-bis(methoxymethoxy)chalcone 10.0 g of the compound obtained above, anhydrous potassium carbonate 6.0
A solution of 1.0 g of potassium iodide in DMF (100 ml) was stirred at room temperature for 60 minutes, then 3.3 d of methyl α-bromoacetate was added, and the mixture was further stirred for 4 hours. After the reaction is complete,
Water was added to the reaction mixture, and the precipitated solid was collected by filtration.
続いて、濾別した固体を酢酸エチルで溶解し、水洗、乾
燥(無水硫酸ナトリウム)したのちに溶媒を留去した.
残留物を酢酸エチル−ジエチルエーテル−ヘキサン系で
結晶化したところ白色の固体として標記の化合物を9。Subsequently, the filtered solid was dissolved in ethyl acetate, washed with water, dried (anhydrous sodium sulfate), and then the solvent was distilled off.
The residue was crystallized from ethyl acetate-diethyl ether-hexane system to obtain the title compound 9 as a white solid.
61g(80%)得た。61 g (80%) was obtained.
分子式:C2□lIzaos(416)融点: 85.
0〜85.5°C
赤外線吸収スペクトル!’ *axCm−’(KBr)
:1770、 1606. 1510, 1428
, 1242, 1212。Molecular formula: C2□lIzaos (416) Melting point: 85.
0~85.5°C Infrared absorption spectrum! '*axCm-' (KBr)
:1770, 1606. 1510, 1428
, 1242, 1212.
1174、 1158, 1128. 10?6. 1
016, 994。1174, 1158, 1128. 10?6. 1
016,994.
プロトン核磁気共鳴スペクトル(200 MZ)δpp
m。Proton nuclear magnetic resonance spectrum (200 MZ) δpp
m.
J 82. (Acetone−d) :63、44(
3H,S)、 δ3.45(311,S) 、 6
3.78(311,S)、 δ4.92(2+1,S
) 、 δ5.25(21L S) 。J82. (Acetone-d): 63, 44 (
3H,S), δ3.45(311,S), 6
3.78 (311, S), δ4.92 (2+1, S
), δ5.25 (21L S).
δ5.27(2+1,S) 、 66、71(1B,
d,J=2.2)、 66、77 (IH, da,
J=2.2, 8.4) 、 67、08(21+
,dd。δ5.27(2+1,S), 66,71(1B,
d, J=2.2), 66, 77 (IH, da,
J=2.2, 8.4), 67, 08 (21+
, dd.
J・2.0, 6.6)、 δ7.64(III,
d,J・15.6)、67、73(IH,d,J≧8.
8)、 67、73(2H,dd,J・2.2。J・2.0, 6.6), δ7.64 (III,
d, J・15.6), 67, 73 (IH, d, J≧8.
8), 67, 73 (2H, dd, J・2.2.
6、6)、 67、85(11(、d,J=15.6
)(2)4.4’−ジヒドロキシ−2−メトキシカルボ
ニルメトキシカルコン
(1)で得た化合物0.50gのメタノール(5rnl
)溶液に塩酸−メタノール4mlを加え45〜50°C
(湯浴中)に加温し、30分間撹拌した。反応終了後、
反応混合物に水を加え、酢酸エチルで抽出したのちに、
水洗、乾燥(無水硫酸ナトリウム)し、溶媒を留去した
。残留物をメタノール−酢酸エチル(少量)−ヘキサン
で結晶化したところ、赤松色粉体として標記化合物を0
.316g(80%)得た。6,6), 67,85(11(,d,J=15.6
) (2) 4.4'-dihydroxy-2-methoxycarbonylmethoxychalcone (1) 0.50 g of methanol (5 rnl
) Add 4 ml of hydrochloric acid-methanol to the solution and heat at 45-50°C.
(in a hot water bath) and stirred for 30 minutes. After the reaction is complete,
After adding water to the reaction mixture and extracting with ethyl acetate,
It was washed with water, dried (anhydrous sodium sulfate), and the solvent was distilled off. When the residue was crystallized from methanol-ethyl acetate (a small amount)-hexane, the title compound was obtained as a red pine colored powder.
.. 316g (80%) was obtained.
分子式: c,t+,、ob(328)融点=207〜
208.0”C
赤外線吸収スペクトルνlIaxcm−’(KBr)
:3408、 3352. 1732. 1722.
1322. 1260。Molecular formula: c, t+,, ob (328) Melting point = 207 ~
208.0"C Infrared absorption spectrum νlIaxcm-' (KBr)
:3408, 3352. 1732. 1722.
1322. 1260.
1240、 1216, 1194, 1186. 1
172プロトン核磁気共鳴スペクトル(200MZ)δ
ppm。1240, 1216, 1194, 1186. 1
172 proton nuclear magnetic resonance spectrum (200MZ) δ
ppm.
Joz、(八cetone−d) :δ3.78(3
1LS) 、64.88 (211,S) 、66.5
0(ill。Joz, (8cetone-d): δ3.78 (3
1LS), 64.88 (211,S), 66.5
0(ill.
d、J・2.2)、 66.58(ill、dd、J
・2.2.8.3)。d, J・2.2), 66.58(ill, dd, J
・2.2.8.3).
δ6.90(20,aa、J=2.0.6.8)、
67.58〜7.71(4H,m)、 67.82(
IH,d、J=15.6)マススペクトルm/z(X)
:
(75)、 107(41)
実施例15
2′−カルボキシメトキシ−4,4′−ジヒドロキシカ
ルコン
前実施例で得た化合物2.5gのメタノール−ジオキサ
ン(75m/−25mり溶液に5%水酸化カリウム水溶
液を50−加え、15分間撹拌した。反応終了後、反応
混合物に水を加え、冷却下で希塩酸を用いて、溶液をp
H6〜4程度に調整し析出した固体を濾取した。濾別し
た固体を減圧加熱乾燥しメタノール−クロロホルム−ヘ
キサンで結晶化したところ、赤橙色の粉体として標記化
合物を1.46g(61%)得た。δ6.90 (20, aa, J=2.0.6.8),
67.58-7.71 (4H, m), 67.82 (
IH, d, J = 15.6) Mass spectrum m/z (X)
: (75), 107(41) Example 15 2'-Carboxymethoxy-4,4'-dihydroxychalcone 2.5 g of the compound obtained in the previous example in methanol-dioxane (75 m/-25 m solution with 5% water 50 ml of potassium oxide aqueous solution was added and stirred for 15 minutes.After the reaction was completed, water was added to the reaction mixture, and the solution was diluted with dilute hydrochloric acid under cooling.
The temperature was adjusted to about H6 to 4, and the precipitated solid was collected by filtration. The filtered solid was dried by heating under reduced pressure and crystallized with methanol-chloroform-hexane to obtain 1.46 g (61%) of the title compound as a reddish-orange powder.
分子式: C+ fi11+ 606 (32B)融点
: 207.0〜208.0°C
赤外線吸収スペクトルシ□xcm−’(KBr) :
3112、 1736. 1634’、 1600.
1536. 1514゜1256、1210.119
0.1172.834プロトン核磁気共鳴スペクトル(
200MZ)δppm。Molecular formula: C+ fi11+ 606 (32B) Melting point: 207.0-208.0°C Infrared absorption spectrum □xcm-' (KBr):
3112, 1736. 1634', 1600.
1536. 1514°1256, 1210.119
0.1172.834 proton nuclear magnetic resonance spectrum (
200MZ) δppm.
J H2,(CDt) 2SO:
64.81(2+1.S)、 66.44(IH,d
、J=2.0) 、 66.49(III、dd、J
P2.帆8.3)、 66.8N2+1.d。J H2, (CDt) 2SO: 64.81 (2+1.S), 66.44 (IH, d
, J=2.0), 66.49(III, dd, J
P2. Sail 8.3), 66.8N2+1. d.
、b8.8)、δ7.54(111,d、J・15.6
)、67.62(Ill。, b8.8), δ7.54 (111, d, J・15.6
), 67.62 (Ill.
d、J=8.3)、 67.82(ill、d、J=
15.6)マススペクトルm/z(χ):
314(M”、 26)、 255(26)、 163
(33)、 137(100)、 107(52)
実施例16
1−(4−1:Fロキシー2−メトキシカルボニルメト
キシフェニル)−3−(4−ヒドロキシフェニル)−1
−プロパノン
(1)1−(2−メトキシカルボニルメトキシ−4−メ
トキシメトキシフェニル)−3−(4−メトキシメトキ
シフェニル)−1−プロパノン
0OCH3
予め水素を吸着させた5%パラジウム−カーボン1.5
gの酢酸エチル懸濁液に実施例14(1)で得た化合物
10.0gの酢酸エチル溶液を加え、更に水素を吸着さ
せた。反応終了後、反応混合物中のパラジウム−カーボ
ンをセライトを用いて除き、濾液を減圧下で濃縮したの
ちにメタノールで結晶化したところ、標記化合物を9.
6g(96%)得た。d, J=8.3), 67.82(ill, d, J=
15.6) Mass spectrum m/z (χ): 314 (M”, 26), 255 (26), 163
(33), 137(100), 107(52) Example 16 1-(4-1:Floxy2-methoxycarbonylmethoxyphenyl)-3-(4-hydroxyphenyl)-1
-Propanone (1) 1-(2-methoxycarbonylmethoxy-4-methoxymethoxyphenyl)-3-(4-methoxymethoxyphenyl)-1-propanone 0OCH3 5% palladium-carbon 1.5 to which hydrogen has been adsorbed in advance
A solution of 10.0 g of the compound obtained in Example 14 (1) in ethyl acetate was added to the suspension of 10.0 g of the compound obtained in Example 14 (1), and hydrogen was further adsorbed. After the reaction was completed, the palladium-carbon in the reaction mixture was removed using Celite, and the filtrate was concentrated under reduced pressure and crystallized from methanol, yielding the title compound 9.
6g (96%) obtained.
分子式: C2411!60t(394)%式%
赤外線吸収スペクトルν□xcm−’(にBr) :
1762、1666、1600.1236.1208.
119B。Molecular formula: C2411!60t(394)% Formula% Infrared absorption spectrum ν□xcm-' (in Br):
1762, 1666, 1600.1236.1208.
119B.
1178、1148.1126.1076、1016.
986プロトン核磁気共鳴スペクトル(200MZ)δ
ppm。1178, 1148.1126.1076, 1016.
986 proton nuclear magnetic resonance spectrum (200MZ) δ
ppm.
J工2.(CDC13) :
62.97(2H,t、J・8.1) 、 63.3
7(211,t、 J・8、1) 、 δ3.46(
6)1.S)、 δ3.74 (3H,S) 、
δ5.14(2H,S)、 δ4.68 (211、
S) 、 δ5.18(2H。J engineering 2. (CDC13): 62.97 (2H, t, J・8.1), 63.3
7(211,t, J・8,1), δ3.46(
6)1. S), δ3.74 (3H,S),
δ5.14 (2H, S), δ4.68 (211,
S), δ5.18 (2H.
S)、66.45(Ill、d、J・2.2)、 6
6.71(in、aa。S), 66.45 (Ill, d, J・2.2), 6
6.71 (in, aa.
J・2.2.8.6)、66.94(2H,da、J・
2.0.6.6)。J・2.2.8.6), 66.94 (2H, da, J・
2.0.6.6).
δ7.16(2+1.dd、J=2.0.6.6)、
67.79(LH。δ7.16 (2+1.dd, J=2.0.6.6),
67.79 (LH.
d、J=8.6)
(2)1−(4−ヒドロキシ−2−メトキシカルボニル
メトキシフェニル)−3−(4−ヒドロキシフェニル)
−1−プロパノン
(1)で得た化合物1.0gのメタノール(10m)溶
液に塩酸−メタノール溶液7.5−を加え40〜45’
C(湯浴中)に加温し30分間撹拌した。反応終了後、
反応混合物に氷水を加え析出した固体を濾取した。減圧
加熱乾燥した固体をメタノール−酢酸エチル(少量)−
石油エーテルで結晶化したところ、白色の粉体として標
記化合物を0.75g(95%)得た。d, J=8.6) (2) 1-(4-hydroxy-2-methoxycarbonylmethoxyphenyl)-3-(4-hydroxyphenyl)
- To a solution of 1.0 g of the compound obtained from 1-propanone (1) in methanol (10 m), add 7.5 - of hydrochloric acid-methanol solution to 40 - 45'
C (in a hot water bath) and stirred for 30 minutes. After the reaction is complete,
Ice water was added to the reaction mixture, and the precipitated solid was collected by filtration. The solid obtained by heating and drying under reduced pressure was mixed with methanol-ethyl acetate (a small amount)-
Crystallization from petroleum ether gave 0.75 g (95%) of the title compound as a white powder.
分子式ニーaft + *Os (380)融点: 1
45.5〜146.5°C
赤外線吸収スペクトルI’ maxCm−’ (KBr
) :3320、1?30.1614.1585.1
514.1254゜プロトン核1a気共鳴スペクトル(
200FIZ)δppm。Molecular formula: aft + *Os (380) Melting point: 1
45.5-146.5°C Infrared absorption spectrum I'maxCm-' (KBr
) :3320,1?30.1614.1585.1
514.1254° Proton nucleus 1a gas resonance spectrum (
200FIZ) δppm.
J H2,(Aceton−d) :δ2.87(2
H,t、J=7.7)、 δ3.33(2)1.t、
J・7.7)、 δ3.72 (3)1. S)
、 δ4.83(21LS)、 δ6.45(II
(、d、J=2.2)、 δ6.53(Ill、dd
、J=8.8゜2.2)、66.73(2)1. dd
、 J・6.6.2.2)、δ7,67(ill、d、
J・8.8)、 67.08(ill、dd、J=2
.2. 6.6)マススペクトルm/z (χ):
330(M”、 75χ) 、 209 (99r)
。J H2, (Aceton-d): δ2.87 (2
H, t, J=7.7), δ3.33(2)1. t,
J・7.7), δ3.72 (3)1. S)
, δ4.83 (21LS), δ6.45 (II
(, d, J=2.2), δ6.53 (Ill, dd
, J=8.8°2.2), 66.73(2)1. dd
, J・6.6.2.2), δ7,67(ill, d,
J・8.8), 67.08(ill, dd, J=2
.. 2. 6.6) Mass spectrum m/z (χ): 330 (M”, 75χ), 209 (99r)
.
xstooo;’@ )、 x2o(99x)、 to
7(9+z)実施例17
■−(2−カルボキシメトキシ−4−ヒドロキシフェニ
ル)−3−(4−ヒドロキシフェニル)=1−プロパノ
ン
前実施例で得た化合物2.63gのメタノール(30m
l)溶液に5%水酸化カリウム水溶液30m1を加え、
室温で15分間撹拌した。反応終了後、反応混合物に水
冷下で希塩酸を加え、溶液を弱酸性に調整したのち、析
出した固体を濾取し、減圧加熱乾燥した。次に乾燥した
固体をメタノールコクロロホルムー石油エーテルで結晶
化したところ、白色の粉体として標記化合物を2.24
g(89%)得た。xstoooo;'@ ), x2o(99x), to
7(9+z) Example 17 -(2-carboxymethoxy-4-hydroxyphenyl)-3-(4-hydroxyphenyl)=1-propanone 2.63 g of the compound obtained in the previous example in methanol (30 m
l) Add 30ml of 5% potassium hydroxide aqueous solution to the solution,
Stirred at room temperature for 15 minutes. After the reaction was completed, dilute hydrochloric acid was added to the reaction mixture under water cooling to make the solution slightly acidic, and the precipitated solid was collected by filtration and dried under reduced pressure by heating. Next, the dried solid was crystallized with methanol, cochloroform, and petroleum ether, and the title compound was obtained as a white powder at 2.24%
g (89%) was obtained.
分子式: C+?ll+60b(316)融点: 16
0.5〜161.0°C
赤外線吸収スペクトルシ□Xcm−’(KBr) :
3160、3048.1?38.1630.1602.
1574゜1260、 1188. 1126. 10
72.992プロトン核磁気共鳴スペクトル(200M
Z)δppm。Molecular formula: C+? ll+60b (316) Melting point: 16
0.5-161.0°C Infrared absorption spectrum □Xcm-' (KBr):
3160, 3048.1?38.1630.1602.
1574°1260, 1188. 1126. 10
72.992 proton nuclear magnetic resonance spectrum (200M
Z) δppm.
J oz、(Solo、八ceton−d) :δ2
.88(211,t、J・7.4)、δ3.33(2H
,t、J・7.4)。J oz, (Solo, 8ceton-d): δ2
.. 88 (211, t, J・7.4), δ3.33 (2H
, t, J・7.4).
64.83(2+1.S) 、 δ6.49 (il
l 、 d 、 J=2.0) 、 66.54(I
H,dd、J=2.0.8.3tlz)、 δ6.7
2(211゜dd、J=2.4.6.4)、 67.
08(2+1.dd)、67.68(111,d、J=
8.3)
マススペクトルm/z(χ):
316(M” 、20)、 195(34)、 1
37(100゜(来夏以下余白)
調剤例1
錠剤の調製
(2) 乳 享店
90g(3) コーンスタ
ーチ 29g(1) 、 (2)及
び17gのコーンスターチを混和し、7gのコーンスタ
ーチから作ったペーストとともに顆粒化、この顆粒に5
gのコーンスターチと(4)を加え、混合物を圧縮錠剤
機で圧縮して錠剤1i2当り(1) 10 +ngを含
有する錠剤1000個を製造する。64.83 (2+1.S), δ6.49 (il
l, d, J=2.0), 66.54 (I
H, dd, J=2.0.8.3tlz), δ6.7
2 (211°dd, J=2.4.6.4), 67.
08(2+1.dd), 67.68(111,d, J=
8.3) Mass spectrum m/z (χ): 316 (M”, 20), 195 (34), 1
37 (100° (margin below next summer) Preparation example 1 Preparation of tablets (2) Nyuu Kyouten
90g (3) Cornstarch Mix 29g (1), (2) and 17g of cornstarch and granulate it with a paste made from 7g of cornstarch.
g of cornstarch and (4) are added and the mixture is compressed in a compression tablet machine to produce 1000 tablets containing (1) 10 +ng per 1i2 tablets.
(来夏以下余白)
調剤例2
カプセル
(2)乳糖 150g
(3) コーンスターチ 100g
(4)結晶セルロース 40g(5)
軽質無水ケイ酸 5g1000個
500 g
常法に従って、上記各成分を混和し、顆粒状としたもの
をカプセル1000個に充填し、1個500mgのカプ
セルを調製する。(Leaving space for next summer) Preparation example 2 Capsule (2) Lactose 150g (3) Cornstarch 100g
(4) Crystalline cellulose 40g (5)
Light anhydrous silicic acid 5g 1000 pieces
500 g According to a conventional method, the above ingredients are mixed and granulated and filled into 1000 capsules, each weighing 500 mg.
調剤例3
注射剤の調製
(2)塩化ナトリウム 9g(3)
クロロブタノール 5g(4)炭酸水素
ナトリウム Ig全成分を蒸留水100
0mfに溶解し、褐色アンプル1000個に1rnlず
つ分注し、窒素ガスで置換して封入する。全工程は無菌
状態で行なわれる。Preparation Example 3 Preparation of injection (2) Sodium chloride 9g (3)
Chlorobutanol 5g (4) Sodium bicarbonate Ig all ingredients in distilled water 100%
Dissolve at 0 mf, dispense 1 rnl into 1000 brown ampoules, replace with nitrogen gas, and seal. The entire process is carried out under aseptic conditions.
〔発明の効果]
以上述べたように、本発明によれば新規なカルコン誘導
体、及び該誘導体を有効成分とする効果のすぐれた抗潰
瘍剤が提供される。[Effects of the Invention] As described above, the present invention provides a novel chalcone derivative and an highly effective anti-ulcer agent containing the derivative as an active ingredient.
Claims (1)
化学式、表等があります▼ 〔式中、 R_1、R_2、R_3、R_4、R_5、R_6は、
同一又は異なり、水素、OH、X、あるいはOX基を表
わすか(Xは、OH、ハロゲン若しくはアルコキシル基
で置換されてもよい直鎖アルキル基を表わす)、又は、
隣接する基と一緒になってアルキレンジオキシを表わし
(但し、すべてが水素原子を表わすことはない); Aは、OH又はO−Y−Zを表わし(Yは、直鎖アルキ
レンを表わし;Zは、カルボキシル、アルコキシカルボ
ニル又は水酸基を表わす);Bは、▲数式、化学式、表
等があります▼、▲数式、化学式、表等があります▼又
は、▲数式、化学式、表等があります▼ を表わし; ▲数式、化学式、表等があります▼は、単結合又は不飽
和結合を意味する。 但し、Bが▲数式、化学式、表等があります▼、2′位
のAがOHを表わし且つ次の(イ)又は(ロ)の場合の
化合物を除く: (イ)5′位がプロピルまたは3−イソペンチルまたは
イソペンテニル基で置換された化合物、 (ロ)4′位(及び/又は6′位)、3位及び4位がO
H基で置換された化合物。〕 2、下記の一般式で示されるカルコン誘導体を有効成分
とする抗潰瘍剤: ▲数式、化学式、表等があります▼ 〔式中、 R_1、R_2、R_3、R_4、R_5、R_6は、
同一又は異なり、水素、OH、X、あるいはOX基を表
わすか(Xは、OH、ハロゲン若しくはアルコキシル基
で置換されてもよい直鎖アルキル基を表わす)、又は、
隣接する基と一緒になってアルキレンジオキシを表わし
(但し、すべてが水素原子を表わすことはない); Aは、OH又はO−Y−Zを表わし;(Yは、直鎖アル
キレンを表わし;Zは、カルボキシル、アルコキシカル
ボニル又は水酸基を表わす);Bは、▲数式、化学式、
表等があります▼、▲数式、化学式、表等があります▼
又は▲数式、化学式、表等があります▼ を表わし; ▲数式、化学式、表等があります▼は、単結合又は不飽
和結合を意味する。 但し、Bが▲数式、化学式、表等があります▼、2′位
のAがOHを表わし且つ次の(イ)又は(ロ)の場合の
化合物を除く: (イ)5′位がプロピルまたは3−イソペンチルまたは
イソペンテニル基で置換された化合物、 (ロ)4′位(及び/又は6′位)、3位及び4位がO
H基で置換された化合物。〕[Claims] 1. Chalcone derivative represented by the following general formula: ▲ Formula,
There are chemical formulas, tables, etc. ▼ [In the formula, R_1, R_2, R_3, R_4, R_5, R_6 are
are the same or different and represent hydrogen, OH,
together with adjacent groups represents alkylene dioxy (however, not all represent hydrogen atoms); A represents OH or O-Y-Z (Y represents straight-chain alkylene; Z represents carboxyl, alkoxycarbonyl, or hydroxyl group); B represents ▲There are mathematical formulas, chemical formulas, tables, etc.▼, ▲There are mathematical formulas, chemical formulas, tables, etc.▼, or ▲There are mathematical formulas, chemical formulas, tables, etc.▼ ; ▲There are mathematical formulas, chemical formulas, tables, etc. ▼ means a single bond or an unsaturated bond. However, this excludes compounds in which B is a mathematical formula, chemical formula, table, etc.▼, A at the 2' position represents OH, and the following (a) or (b) is true: (a) The 5' position is propyl or Compounds substituted with 3-isopentyl or isopentenyl group, (b) 4'-position (and/or 6'-position), 3- and 4-positions are O
Compounds substituted with H groups. [In the formula, R_1, R_2, R_3, R_4, R_5, R_6 are
are the same or different and represent hydrogen, OH,
together with adjacent groups represents alkylene dioxy (however, not all of them represent hydrogen atoms); A represents OH or O-Y-Z; (Y represents straight-chain alkylene; Z represents carboxyl, alkoxycarbonyl or hydroxyl group); B represents ▲ mathematical formula, chemical formula,
There are tables, etc. ▼, ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼
Or ▲There are mathematical formulas, chemical formulas, tables, etc.▼ means; ▲There are mathematical formulas, chemical formulas, tables, etc.▼ means a single bond or an unsaturated bond. However, this excludes compounds in which B is a mathematical formula, chemical formula, table, etc.▼, A at the 2' position represents OH, and the following (a) or (b) is true: (a) The 5' position is propyl or Compounds substituted with 3-isopentyl or isopentenyl groups, (b) 4'-position (and/or 6'-position), 3- and 4-positions are O
Compounds substituted with H groups. ]
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6576888A JPH01242540A (en) | 1988-03-22 | 1988-03-22 | Novel chalcone derivative and antiulcer agent containing said derivative as active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6576888A JPH01242540A (en) | 1988-03-22 | 1988-03-22 | Novel chalcone derivative and antiulcer agent containing said derivative as active ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01242540A true JPH01242540A (en) | 1989-09-27 |
Family
ID=13296531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6576888A Pending JPH01242540A (en) | 1988-03-22 | 1988-03-22 | Novel chalcone derivative and antiulcer agent containing said derivative as active ingredient |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01242540A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011662A1 (en) * | 1993-10-26 | 1995-05-04 | Unilever Plc | Cosmetic composition comprising a hydrocalchone and optionally retinol or a derivative thereof |
WO1997043235A1 (en) * | 1996-05-14 | 1997-11-20 | Hoechst Marion Roussel Ltd. | Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same |
KR19990085334A (en) * | 1998-05-15 | 1999-12-06 | 성재갑 | Method for preparing benzyloxychalcone derivative and purification method thereof |
KR19990085333A (en) * | 1998-05-15 | 1999-12-06 | 성재갑 | Method for preparing 1,3-diphenyl propenone derivative |
US6838099B2 (en) | 2000-10-24 | 2005-01-04 | Samyang Genex Corporation | Method for preparing soluble dietary fiber from corn hull |
JP2009508900A (en) * | 2005-09-20 | 2009-03-05 | レボタール・バイオファーマシューティカルズ・アーゲー | Novel phloroglucinol derivatives with selectin ligand activity |
JP2010539150A (en) * | 2007-09-14 | 2010-12-16 | スクール オブ ファーマシー,ユニバーシティ オブ ロンドン | Antibacterial agent |
WO2013038136A1 (en) * | 2011-09-16 | 2013-03-21 | The University Of Surrey | BI-AROMATIC AND TRI-AROMATIC COMPOUNDS AS NADPH OXIDASE 2 (Nox2) INHIBITORS |
-
1988
- 1988-03-22 JP JP6576888A patent/JPH01242540A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011662A1 (en) * | 1993-10-26 | 1995-05-04 | Unilever Plc | Cosmetic composition comprising a hydrocalchone and optionally retinol or a derivative thereof |
WO1997043235A1 (en) * | 1996-05-14 | 1997-11-20 | Hoechst Marion Roussel Ltd. | Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same |
US6177474B1 (en) | 1996-05-14 | 2001-01-23 | Hoechst Marion Roussel | Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same |
KR19990085334A (en) * | 1998-05-15 | 1999-12-06 | 성재갑 | Method for preparing benzyloxychalcone derivative and purification method thereof |
KR19990085333A (en) * | 1998-05-15 | 1999-12-06 | 성재갑 | Method for preparing 1,3-diphenyl propenone derivative |
US6838099B2 (en) | 2000-10-24 | 2005-01-04 | Samyang Genex Corporation | Method for preparing soluble dietary fiber from corn hull |
JP2009508900A (en) * | 2005-09-20 | 2009-03-05 | レボタール・バイオファーマシューティカルズ・アーゲー | Novel phloroglucinol derivatives with selectin ligand activity |
JP2010539150A (en) * | 2007-09-14 | 2010-12-16 | スクール オブ ファーマシー,ユニバーシティ オブ ロンドン | Antibacterial agent |
WO2013038136A1 (en) * | 2011-09-16 | 2013-03-21 | The University Of Surrey | BI-AROMATIC AND TRI-AROMATIC COMPOUNDS AS NADPH OXIDASE 2 (Nox2) INHIBITORS |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH03188042A (en) | Quinone derivative | |
JPH02149545A (en) | Novel lignans and protease inhibitor using lignans or phenylpropanes as active ingredient | |
PT92378B (en) | PROCESS FOR THE PREPARATION OF CHROMAN DERIVATIVES, ACTIVES ON THE CENTRAL NERVOUS SYSTEM | |
US3830934A (en) | Analgesic and antitussive compositions and methods | |
CA3093234A1 (en) | Adenosine receptor antagonists and uses thereof | |
JPH03505335A (en) | Novel sulfonamides derived from benzocyclic or benzoheterocyclic acids, their production methods and their pharmaceutical uses | |
JPH10511084A (en) | Polyarylcarbamoylaza and carbamoylalkanediacid | |
JPH08504419A (en) | Use of aryloxyalkyl-substituted cyclic amines as calcium channel antagonists and novel phenyloxyalkylpiperidine derivatives | |
JPH01190688A (en) | Pyprolizidine compound and use thereof | |
JPH01242540A (en) | Novel chalcone derivative and antiulcer agent containing said derivative as active ingredient | |
KR100281867B1 (en) | 3- (bis-substituted phenylmethylene) oxindole derivatives | |
JPS63290868A (en) | Diketopiperazine derivative and salts thereof | |
US4134991A (en) | Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid | |
CA2022236A1 (en) | Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders | |
US3953453A (en) | Trifluoromethyl substituted analogs of quinine and quinidine | |
AU2005296674B2 (en) | Ester derivative and pharmaceutical use thereof | |
US4206213A (en) | Dithienylalkylamines and process for their production | |
FR2521992A1 (en) | NOVEL PYRIDINE COMPOUNDS USEFUL AS MEDICAMENTS | |
JPH0118899B2 (en) | ||
EP0732329A1 (en) | Chroman derivative | |
HUT61966A (en) | Process for producing new phenylalkyl aminoalkyl derivatives and pharmaceutical compositions comprising such compounds | |
KR890000021B1 (en) | Aryloxycycloalkanol amino alkylene aryl ketone and process of preparing thereof | |
US3883565A (en) | Ester of {60 -tocopherol | |
US3766245A (en) | 3,5-dialkoxyalkoxy-4-substituted benzoic acid esters | |
EP0304222A2 (en) | Amino-2-hydroxypropyloximino-heterocycle beta blockers |